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GENERAL INTRODUCTION 
In a multicellular organism, intercellular and 
intertissue communications are of primary importance in 
keeping the animal alive. This communication between cells 
or cell populations is achieved by chemical signals such as 
hormones and neurotransmitters that constitute the first 
messengers. These chemical signals are picked up only by 
certain cells, called target cells, that have specific cell 
surface membrane proteins (receptors). These membrane 
proteins recognize and bind a specific chemical signal. The 
signal generated as a result of agonist binding to its 
receptor, has to travel through the plasma membrane, to 
bring about generation of an intracellular second messenger, 
unless the agonist itself enters the cell. In case where 
the agonist, after binding to the receptor, is not able to 
enter the cell, the major barrier to the flow of information 
across the plasma membrane is overcome by a protein or 
proteins in the cell membrane that transmit information by 
chemical and physical alterations to itself or to effector 
proteins. The end result of the signal transduction process 
from outside the cell through the plasma membrane, is the 
generation of second messengers. Second messengers may be 
in the form of altered membrane lipids, ions which enter 
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through ion channels, phosphorylated membrane proteins, or 
cAMP generated by a membrane-bound adenylyl cyclase system. 
In 1956, Sutherland and his group, studied the effects 
of epinephrine and glucagon on activation of phosphorylase 
in liver homogenates. They found that, a particulate 
fraction of the liver homogenate produced a heat-stable and 
dialyzable factor in presence of the hormones, and this 
factor stimulated liver phosphorylase activity in 
supernatant fractions of these homogenates, in which hormone 
themselves were inactive (l). This heat-stable factor was 
later identified as cyclic adenosine monophosphate (cAMP), 
and it was found not only in the liver, but also in heart, 
skeletal muscle and brain (2,3). Later studies by various 
groups confirmed this second messenger system to be present 
in all animals. The adenylyl cyclase system is one of the 
most extensively studied second messenger systems. It is a 
hormonally responsive, membrane-bound multicomponent system, 
comprising three physically distinct and separable entities: 
receptors for stimulatory (Rg) and inhibitory (Rj^) hormonal 
inputs, guanine nucleotide and Mg^"*"-binding regulatory 
components (Gg and G^) to transduce the stimulatory and 
inhibitory hormone-receptor messages, and a catalytic unit 
(£)/ that converts Mg-ATP to cAMP. 
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The Catalytic Unit of the Adenvlvl Cyclase System The 
catalytic unit of adenylyl cyclase is a membrane bound 
enzyme, having a molecular weight of approximately 150 kDa 
(4,5) and can be resolved from Gg and without loss of 
activity (6,7). £ was purified from Neurospora crassa in 
1982 by Reig et al. (8) and later from bovine brain by 
Smigel in 1986 (9). Both Mg-ATP and Mn-ATP can act as 
substrates for Q in the presence of Gg and only Mn-ATP in 
its absence (10). Very little is known about the structure 
of the catalytic moiety. 
Signal Transteing g Proteine <?£ AdenylYl Gyflaee 
More is known about the guanine nucleotide and Mg2+-binding 
regulatory components of the cyclase system. In recent 
years, such vast amounts of information have been gathered 
on the signal transducing G proteins, that it is fitting to 
discuss them separately. 
Gg: The stimulatory regulatory component of adenvlvl 
cyclase Rodbell's group in 1971 (11,12) were the first 
to provide evidence for a stimulatory role of GTP in the 
regulation of adenylyl cyclase. Subsequently GTP-binding 
proteins in solubilized pigeon erythrocyte membranes were 
identified that activated adenylyl cyclase in rabbit 
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myocardial adenylyl cyclase preparations depleted of the 
binding proteins (13). In 1980, a component that bound GTP 
and mediated hormonal stimulation of adenylyl cyclase was 
purified by Oilman's group (14), which they called G/F and 
later Gg (15). Gg was found to be a heterotrimeric complex 
composed of aiBha/ beta and gamma subunits (16). The 
establishment of Gg as the stimulatory regulatory component 
of adenylyl cyclase was demonstrated by its ability to 
reconstitute the adenylyl cyclase system of eye" cells (eye" 
I 
cells are derived from the S49 lymphoma cell line and lack 
the of Gg, even though stimulatory receptors and the 
adenylyl cyclase catalytic moiety are present), and the 
simultaneous restoration of cholera toxin labeling to the 
same cells (14,17). Cholera toxin, a bacterial toxin from 
Vibrio cholera, produces its effect by stimulating the 
adenylyl cyclase system. Subsequently it was found that 
âlfibâs of Gg possesses GTPase activity and is a substrate 
for the ADP-ribosyltransferase activity of cholera toxin 
(14,17). Based on studies performed on transducin (18) it 
is believed that cholera toxin ADP-ribosylates alpha^ on an 
arginine residue, and by doing so, inhibits the GTP 
hydrolyzing capability of this subunit. More recently, pure 
Gg has been shown to stimulate purified £ (9,19) of adenylyl 
cyclase, both in solution and when reconstituted into 
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phospholipid vesicles (20). The alpha subunit of Gg binds 
(21) I 6TP and 6TP analogs (22). In the presence of 
Mg^*** and nonhydrolyzable 6TP analogs, and also in the 
presence of F" and Al^*, Gg can be activated and undergo 
dissociation to beta-gamma and alDha subunits (6,7,22-28). 
The alpha subunits of G proteins have been cloned by various 
groups (29-34) and their amino acid composition deduced from 
their cDNA sequences. SDS-PAGE and urea gradient PAGE 
indicate the existence of two beta subunits in 6 proteins, 
Mr= 35,000 and 36,000. The amino acid sequence of both 
types of beta subunits, have been deciphered from their cDNA 
sequences (35-38). The amino acid sequence of gamma subunit 
is not yet known. Some functional domains on Gg have been 
identified, one regulates the catalytic activity of g and 
the other regulates receptor function. Our knowledge of the 
existence of the two functional domains on Gg comes from the 
study of Gg in S49 lymphoma UNC variants (39,40). Gg in UNC 
variants is not stimulable by stimulatory hormones even 
though normal guanine nucleotide and fluoride sensitivity of 
catalytic activity are maintained. Recently, the aloha Gg 
from UNC has been cloned and the defect responsible has been 
identified as the replacement of proline in place of an 
arginine at position 372 of the alpha^ polypeptide (41). 
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Studies using intact membranes have shown that 
stimulation by a hormone decreases Mg^"*" requirement for Gg 
activation by a factor of 1000 (from 5-15mM to 5-15uM) 
(21,42). The exact mechanism by which this hormone-receptor 
complex facilitates activation of Gg by GTP is not known. 
Experiments where pure Gg have been incorporated into 
phospholipid vesicles show that Gg exhibits very low GTPase 
activity, in the order of 0.02 to 0.05 mol hydrolyzed per 
min per mol of Gg (43). Incorporation of pure beta-
adrenergic receptors into the above vesicles increases the 
rate of GTP hydrolysis by Gg by a factor of 2-3. On 
addition of a beta-adrenergic agonist (isoproterenol) to 
this reconstituted system, there is a further potentiation 
of the GTP hydrolysis rate 10-20 fold (1 mol min"^ per mol 
of Gg) (43,44). Studies have shown that GDP has a higher 
affinity for Gg than GTP and that Gg-GDP is the inactive 
form of the transducing protein (45). So it is very likely 
that hormone increases the affinity of Gg for GTP, via 
decreasing the Mg^"*" requirement for Gg, thus facilitating 
the dissociation of GDP from Gg and binding of GTP, thereby 
augmenting the rate of turnover of GTP by Gg. Addition of a 
stimulatory hormone to the cyclase system, as present in 
biological membrane preparations, also results in 
stimulation of the low Km GTPase activity of Gg (46,47). 
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This was first reported in 1976 by Cassel and Selinger 
(46), from their studies on catecholanine-stimulated GTPase 
activity in turkey erythrocyte membranes. 
:The inhibitory rgçpAlatprv çf aOgnYlYl 
cyclase The basis for the bimodal regulation of the 
adenylyl cyclase system was first indicated when in 1973-74 
Birnbaumer's group first reported the inhibition of adenylyl 
cyclase in beef renal medullary cell membranes at uM 
concentrations of 6TP (48,49). Subsequently, studies 
further suggested that hormones which attenuated adenylyl 
cyclase activity did so via a GTP-dependent mechanism, where 
the 6TP requirement was very low. In 1982, Katada and Ui 
(50) reported that a bacterial toxin, called pertussis toxin 
or islet-activating protein from Bordetella pertussis that 
caused whooping cough in children, is able to directly 
modify the adenylyl cyclase system in rat pancreatic islets 
by ADP-ribosylation of a membrane protein. In 1983, 
Birnbaumer's group, using the eye" mutant of S49 lymphoma 
cells were able to study the putative Gj^ in absence of Gg 
and thereby establish the existence of distinct stimulatory 
and inhibitory regulatory proteins of adenylyl cyclase (51). 
The pertussis toxin substrate was purified from rabbit liver 
in 1983 by Gilman's group (52). It was first shown to be an 
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alpha-beta-aamma heterotrlner by Hlldebrandt et al. (16) and 
was also shown to be regulated by guanine nucleotide and 
Mg^"*" (52-54). The alfiliai protein purified from the liver 
(52) has a molecular weight of 41,000 and the one purified 
from human RBC has a molecular weight of 40,000. Recent 
findings indicate that pertussis toxin in the presence of 
^^P-NAD"*" labels transducin at cysteine residue 347 (55). 
Thus functionally, like Gg is a Mg^"*" and GTP-binding 
protein with GTPase activity, but differs from Gg in that 
its affinity for Mg^"*" is very high, so much so that uM 
concentrations of Mg^"*" are sufficient to satisfy G^ for its 
activation by guanine nucleotides. Therefore, under 
physiological conditions, G^ is saturated by both Mg^*^ and 
guanine nucleotides. Unlike Gg, ADP-ribosylation of aloha 
of G^ by pertussis toxin results in the loss of its ability 
to interact with inhibitory receptors, (56). ADP-
ribosylation of alphais also responsible for inhibition of 
GTPase activity of the G^ protein. Like Gg, the hormone 
activation of Gj^ increases GTP hydrolysis, and increases 
release of prebound GDP (57). The exact mechanism by which 
activated G^ attenuates £ activity is not clear. The beta 
and gamma subunits of both Gg and G^ are similar. 
Inhibitory adenylyl cyclase receptors (R^) that 
activate G^ to inhibit £ are: muscarinic acetylcholine, 
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somatostatin, angiotensin II, opioid, and 
dopamine receptors (58-65). The complex increases 
nucleotide exchange at Gj^. This has been established for 
alBha2-adrenergic receptor action on human platelet 
membranes (66). 
Hormone binding to receptortits regulation Studies to 
date indicate that occupancy of a receptor by a specific 
ligand is not sufficient to trigger Gg or Gj^ activation. On 
the other hand, only specific agonist binding leads to the 
activation of Gg and G^. A specific ligand that binds to a 
receptor type but does not elicit a response, is termed an 
antagonist, as opposed to an agonist (ligand that elicits a 
response). 
In membrane preparations, the binding of a hormone to 
its receptor is regulated in a guanine nucleotide- and Mg^*-
dependent fashion (11,67). Guanine nucleotide regulation of 
hormone receptor binding was first demonstrated by Rodbell 
et al. in 1971 (11), who showed that GTP lowered the 
affinity of hepatic glucagon receptors for its hormone. 
This guanine nucleotide-dependent decrease in receptor 
affinity has since been demonstrated in a number of 
stimulatory and inhibitory hormones (68) with the exception 
of parathyroid hormone (69) and glycoprotein hormones (70-
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74). The Mg2+-dependent regulation of hormone-receptor 
binding was first demonstrated by Williams et al. in 1978 
(67) for beta-adrenergic agonists in frog erythrocytes. In 
contrast to guanine nucleotide, Mg^"*" generally increases 
receptor affinity for hormones. One known exception to this 
Mg2+-dependent regulation of hormone-receptor binding is the 
glucagon receptor in rat liver plasma membranes that is 
insensitive to Mg^"*" (75). As mentioned earlier, it is the 6 
protein that regulates the affinity states of the receptor. 
This role of Gg was demonstrated by using eye" variant of 
the S49 murine lymphoma cell line. Due to lack of Gg (76) 
cyc~ variants do not demonstrate either guanine nucleotide-
(77) or Mg2+-dependent (78) effects on receptor affinity. 
Complementing eye" membranes with detergent extracts from 
wild-type membranes containing Gg restores this regulation 
(79). Studies by Cerione et al. in 1984, using pure beta-
adrenergie receptors and pure Gg reconstituted into 
phospholipid vesicles, confirm the role of Gg in the 
regulation of hormone-receptor binding (43). These 
reconstitution studies indicate that Gg regulates the high 
and low affinity states of the receptor for its agonist. In 
the absence of Gg all receptors are in their low affinity 
states. Although the exact mechanism for this phenomenon is 
unknown, there are various arguments to explain it. It has 
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been argued that since Gg activity is Mgf* and GTP 
dependent, the most likely mode of events is that 
binding to Gg causes the Gg protein to change conformation, 
so that it interacts with the receptor to stabilize it in 
its high affinity state. An alternate mechanism, however, 
cannot be ruled out: that only in the presence of Gg can the 
receptor bind Mg^"*", to shift from its low to its high 
affinity state. The later mechanism could be argued on the 
basis of the following findings by Neufeld et al., 1983 and 
Nedivi and Schramm, 1984 (80,81). Schramm and collaborators 
found that under special circumstances, a Mg^^-dependent 
high affinity form of hormone-receptor complex can be 
obtained after inactivation of Gg by alkali treatments, 
suggesting that an additional Mg^^-binding site may exist 
(possibly on the receptor) and participate in receptor 
regulation. 
Desensitization Prolonged exposure of target cells to a 
hormone often results in reduced responsiveness of the cells 
to rechallenge with the same hormone. These phenomena of 
refractoriness of cells to hormonal rechallenge is termed 
desensitization. The desensitization process is widely 
observed both In prokaryotic and eukaryotic systems (82-86). 
In case of receptors coupled to the adenylyl cyclase system, 
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two different types of desensitlzatlon are observed. 
Homologous or "agonist-specific" desensitization is a 
process whereby, the exposure to one type of agonist results 
in refractoriness of cells to only the same class of 
agonists. Heterologous desensitization on the other hand, 
is characterized by diminished responsiveness of cells, not 
only to the hormone it was first challenged with, but to 
other hormones as well. 
Homologous Desensitization This form of 
desensitization is characterized by functional uncoupling of 
the receptors and their sequestration by internalization 
within the cell. The former step called 'desensitization' 
and the latter step termed 'down-regulation' are temporally 
well separated processes. This has been demonstrated in 
human astrocytoma (87,88) and S49 mouse lymphoma cells (89) 
in response to catecholamines and in the testes in response 
to gonadotropins (90). This form of desensitization is not 
CAMP mediated (91). Recent studies (92,93) in smooth muscle 
cells and frog erythrocytes indicate that in homologous 
desensitization of the beta-adrenergic receptor coupled to 
adenylyl cyclase the receptors undergo phosphorylation. In 
the same studies, the authors have examined the functional 
activity of the phosphorylated beta-adrenergic receptor by 
reconstituting purified receptor with purified Gg in 
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phospholipid vesicles and then determined the receptor-
stimulated GTPase activity of the GTP-binding stimulatory 
transducing protein. In comparison to non-phosphorylated 
controls, phosphorylated beta-adrenergic receptors, purified 
from desensitized cells, were less efficacious in 
stimulating Gg-GTPase activity (93). These studies (92) 
also show the presence of a cytosolic 'beta-adrenergic 
receptor kinase', that is translocated from the cytosol to 
the plasma membrane and which phosphorylates the beta-
receptor, but only when the latter is occupied by an 
agonist. Studies also show that there is no change in the G 
protein activity upon homologous desensitization (89). 
Heterologous Deaensltization This process is less 
well understood than homologous desensitization. In 
contrast to homologous desensitization, heterologous 
desensitization as examined in frog erythrocytes (94-97) and 
cultured cells (98,99), is not associated with receptor down 
regulation of the heterologous receptor but instead 
primarily involves receptor-adenylyl cyclase uncoupling. 
Studies carried out in the past few years on the beta-
adrenergic receptor coupled adenylyl cyclase system indicate 
that heterologous desensitization of this system is 
associated with receptor phosphorylation, and that this 
could primarily be responsible for the receptor-adenylyl 
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cyclase uncoupling (100-103). These studies also show that 
this beta-adrenergic receptor phosphorylation is mediated 
partly by cAMP-dependent protein kinase (100-103). 
Therefore, unlike homologous desensitization, heterologous 
desensitization is cAMP-dependent. Studies also suggest 
changes in 6 proteins on heterologous desensitization (104). 
The corpus luteum In the ovary, follicles mature under 
the influence of FSH and continued estrogen supply. During 
follicular maturation, LH receptors are induced (105,106), 
that are coupled to the adenylyl cyclase (107-111). Mature 
follicles respond to low LH levels by secreting variable 
amounts of progesterone, androgens and estradiol (112-117). 
The estrogen secreted by mature follicles acts as a positive 
feedback on the hypothalamus and pituitary, such that there 
is an LHRH release from the hypothalamus, resulting in an 
ovulatory LH surge by the pituitary (118-120). In response 
to this high level of LH mature follicles ovulate. The 
exact mechanism of the ovulatory process is not known. 
After ovulation, both the theca and granulosa cells of the 
follicles undergo luteinization, as well as secreting 
prostaglandin and large quantities of estrogen and 
androgens. Most of these effects of LH on mature follicles 
have been shown to be cAMP mediated (121-124). After 
15 
stimulation of the LH-receptor coupled adenylyl cyclase by 
LH, the system rapidly enters a refractory state with 
respect to further stimulation by LH (111). The newly 
formed luteal cells are steroidogenically quiescent 
(114,125,126). Depending on the species, the new CL starts 
producing progesterone either rapidly, in the case of the 
rat (48h post ovulation), or slowly, in the case of the 
rabbit (3 to 4 days after ovulation) (127,128). In the 
rabbit newly formed CL are devoid of estradiol receptors, 
but within 3 to 4 days estradiol receptors develop 
(129,130). Studies show that in rabbits, 17 beta-estradiol 
of follicular origin is the essential luteotrophic hormone 
(131). In rabbits the life span of the CL of pregnancy is 
32 days (129). If pregnancy fails, the rabbit CL persists 
for about 16 days prior to regression. Reasons for CL 
regression are unknown. Studies show that the CL of 
pregnancy and pseudopregnancy in the rabbit are very similar 
(132,133). Estrogen supply (132) and the development of LH-
stimulable adenylyl cyclase activities (133) are similar in 
CL of both pregnant and pseudopregnant rabbits. 
Studies by Marsh (134) in 1970, were the first to 
demonstrate the existence of LH-stimulable adenylyl cyclase 
in the corpus luteum. Two years later, the existence of LH 
receptors in the corpus luteum was demonstrated by Lee and 
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Ryan (135) and Tsuruhara et al. (136). Subsequently, 
studies by Birnbaumer et al. in 1976 demonstrated 
catecholamine stimulable adenylyl cyclase in the corpus 
luteum (137) and later the presence of beta-adrenergic 
receptors in the corpora lutea of rabbits was demonstrated 
by Abramowitz et al. in 1982 (138). It was found that LH 
increases cAMP levels in luteal homogenates and slices, and 
that exogenous cAMP mimicked the effects of LH. 
Phosphodiesterase inhibitors were also shown to potentiate 
LH effects (139). The corpus luteum of rabbits contains an 
adenylyl cyclase system that is not only responsive to LH 
and beta-adrenergic agonists (137,139,79), but is also 
stimulated by prostaglandins (137) and prostacyclins (140) 
and is attenuated by enkephalins (141). stimulation of the 
luteal adenylyl cyclase in rabbits by both LH and beta-
adrenergic agonists demonstrates both a guanine nucleotide 
and magnesium requirement. Both LH and beta-adrenergic 
agonists are not additive at saturating concentrations, 
suggesting that they are acting on the same cyclase system 
(137). On the other hand, there exists differences in 
binding and regulation of these hormones (LH and beta-
adrenergic) to their receptors and their stimulation of 
adenylyl cyclase activity. LH or hCG binding to rabbit 
luteal receptors is insensitive to guanine nucleotide (79) 
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and is irreversible (74). This irreversible binding of 
gonadotropins to their luteal receptors is associated with 
the persistent activation of luteal cyclase in luteal 
membrane preparations. Exposure of Graafian follicles or 
corpora lutea to ovulatory doses of LH or hCG, renders these 
structures unresponsive to further stimulation by LH 
(142,143,133). Thus, dissociation of this hormone from its 
receptor may not be the physiologically relevant mechanism 
for deactivation of LH-stimulated adenylyl cyclase. Studies 
show that LH-stimulable adenylyl cyclase activity in rabbit 
CL of pregnancy or pseudopregnancy fluctuates (133,144) and 
parallels progesterone output of the tissue (145,146). 
Since LH- and h@6a-adrenergic-receptors are both coupled to 
the same adenylyl cyclase system, and since LH acutely 
affects luteal steroidogenesis, understanding the regulation 
of the luteal adenylyl cyclase coupled to these two receptor 
systems would help gain further insight on luteal function. 
In view of this, studies were undertaken that involved 
assessment of the different components of the adenylyl 
cyclase system after injection of either hCG or epinephrine 
to pseudopregnant female rabbits. 
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Llgand 
LH/hCG (agonist) 
Epinephrine (agonist) 
Isoproterenol (agonist) 
ICYP (antagonist) 
NaF (agonist) 
Forskolin (agonist) 
Cholera toxin 
Pertussis toxin 
Adenylyl cyclase site of action 
LH/hCG receptors 
beta-adrenergic receptors 
beta-adrenergic receptors 
beta-adrenergic receptors 
Gg protein 
Catalytic site 
ADP-ribosylates Gg 
ADP-ribosylates Gj^ 
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EXPLANATION OF DISSERTATION FORMAT 
This dissertation is written in the alternate format. 
Each major division (Sections I-III) is modified to conform 
with the specifications of the Iowa State University Thesis 
Office. Each section has its own abstract, introduction, 
materials and methods, results, discussion and references. 
Following these three sections, is a general discussion of 
the entire dissertation. 
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SECTION I. hCG-INDUCED HETEROLOGOUS DESENSIÏIZATION OF 
RABBIT LUTEAL ADENYLYL CYCLASE. 
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ABSTRACT 
The corpus luteum in rabbits contains an adenylyl 
cyclase system that is responsive to both LH and beta-
adrenergic agonists. Earlier studies in rats and rabbits 
indicate that gonadotropin-induced desensitization of their 
luteal adenylyl cyclase involves reduced responsiveness of 
the enzyme to both LH and catecholamines. The present study 
was conducted to determine changes in the adenylyl cyclase 
components in luteal membranes from pseudopregnant rabbits 
that had been subjected to an intravenously injected 
desensitizing dose of hCG (100 lU) and then killed at 3, 6, 
12, 24 and 48 h post injection. Enzyme activity in rabbit 
luteal membranes from control (0.9% saline i.v.) and 
desensitized (100 lU hCG i.v.) animals was determined in 
presence and absence of oLH, ISO, NaF and forskolin. Both 
hCG receptors and bSÈâ-adrenergic receptors were assessed by 
Scatchard analysis. Total and available hCG receptors were 
guantitated and analyzed for each time point by means of an 
acid elution procedure that was developed for this purpose. 
This procedure enabled the dissociation of hCG from its 
receptor without altering the affinity or concentration of 
receptors present. Changes in Gg activity were assessed by 
33 
the ability of chelate extracts of luteal membranes to 
reconstitute NaF- and ISO-stimulable adenylyl cyclase 
activity in S49 eye" membranes. Changes in Gg- and Gj^-like 
proteins were measured by utilizing the ability of cholera 
toxin and pertussis toxin to ADP-ribosylate the alpha 
subunits of Gg- and G^-like proteins respectively. hCG-
induced desensitization resulted in a rapid loss in LH-
stimulable adenylyl cyclase activity (41% at 6 h) and a 
delayed loss in catecholamine-stimulable cyclase activity 
(25% at 12 h). Both LH- and ISO-stimulable adenylyl cyclase 
activity continued to decline until 24 h when a loss of 67% 
and 50% respectively was observed. Changes in NaF- and 
forskolin-stimulable cyclase activity were also observed. 
hCG treatment resulted in a time dependent loss of both hCG 
receptors and bStâ-adrenergic receptors. At earlier time 
points (3 h-12 h) there was little loss in total number of 
hCG receptors. At 12 h, occupied hCG receptors had a 5 fold 
lowered affinity (Kd = 1.67) for hCG, than found in 
controls. There was no change in beta-adrenergic receptor 
number until 12 h, after which there was a time dependent 
decrease. Changes in NaF-reconstituted activity paralleled 
changes in NaF-stmulated luteal adenylyl cyclase activity. 
There was a preferential loss of ISO-reconstituted activity, 
prior to NaF-reconstituted activity following hCG treatment. 
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Three cholera toxin substrates (aiEhâg 42, alpha^ 45 and 
alphag 46) and one pertussis toxin substrate falpha40) 
were identified. hC6 treatment resulted in a selective 
depression of alpha^ 45 and an elevation of alpha40. 
Thus, gonadotropin-induced desensitization of the rabbit 
luteal adenylyl cyclase resulted in both homologous and 
heterologous desensitization. Until 12 h, the 
desensitization of luteal cyclase was homologous. At the 12 
h time point, there was a loss of both LH- and 
catecholamine-stimulable adenylyl cyclase; as well as loss 
in LH- and hgta-adrenergic receptor, indicating heterologous 
desensitization. The early loss of ISO-reconstituted 
activity, prior to loss in NaF-reconstituted activity, 
indicates the existence of a NaF-acting site on Gg that is 
separate from the receptor coupling domain on Gg. The 
preferential loss in ability of alpha^ 45 to be ADP-
ribosylated by cholera toxin following hCG treatment, 
suggests that there may be preferential interaction of the 
LH/hCG receptor with this isomorph of alpha Gg. 
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INTRODUCTION 
In the adenylyl cyclase system, as well as in other 
systems, hormonal occupancy of a receptor leads to 
stimulation, that is later followed by attenuation. These 
phenomena of attenuation or refractoriness following 
stimulation is termed desensitization. Studies carried out 
earlier in both rats and rabbits indicate that hCG-induced 
desensitization of luteal tissue is heterologous in nature 
(1-3); i.e., the adenylyl cyclase loses responsiveness not 
only to the hormone that induced desensitization, but also 
to other stimulating ligands. Earlier studies by Lee and 
Ryan, 1972-73 (4,5); Amir-Zaltsman and Salomon, in 1980 (6) 
and Labarbera et al. also in 1980, (7) report that luteal 
gonadotropin receptors that are coupled to and stimulate 
adenylyl cyclase, bind their hormone extremely tightly and 
dissociate very slowly, if at all reversible. 
Desensitization to hCG has also been shown to result in 
lowered response of cyclase activity to cholera toxin in 
intact cells (2,8), as well as lowered fluoride stimulable 
adenylyl cyclase activity in isolated membrane preparations 
(1,2,9,10). Studies by Abramowitz and Birnbaumer in 1982 
reported that hCG binding to rabbit luteal membranes is 
irreversible, and that this irreversible binding leads to 
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persistent stimulation of the cyclase system in these 
membranes (11). 
In view of this, and in order to understand some of the 
mechanisms involved in hCG-induced in vivo desensitization 
of the rabbit luteal adenylyl cyclase system, studies were 
undertaken to assess alterations in this system, post 
intravenous injection of a desensitizing dose of hC6 (100 
lU) to pseudopregnant animals. 
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MATERIALS AND METHODS 
Material Inorganic was purchased from 
International Chemical and Nuclear Corp. (Irving, CA). 
[^H]cAMP (10-20 Cl/mMol) was from Schwarz/Mann (Orangeburg, 
NY). ATP, EDTA, Trls, dlsodlum creatine phosphate, creatine 
phosphoklnase, myoklnase, human chorionic gonadotropin 
(hCG), porcine follicle stimulating hormone (FSH), cholera 
toxin (CT+) , bsÊa-mercaptoethanol, guanoslne triphosphate 
(6TP), dlthlotreltol (DTT), thymidine, ADP-rlbose and 
arglnlne were from Sigma Chemical Co. (St. Louis, MO). 
Forskolln was from Calblochem (LaJolla, CA). Ovine LH 
(oLH) was from NIH, lot # oLH-23, AFP4570-B. (-) 
Isoproterenol was from Sterllng-Wlnthrop Research Institute 
(Rensselaer, NY). [alpha-^^P]ATP (SA,>50 Cl/mmol) was 
synthesized according to the procedure of Walseth and 
Johnson (12). [32p]NAD* was synthesized according to the 
procedure of Cassel and Pfeuffer (13). hCG was 
radolodlnated to [^^®I]lodo-hCG by a procedure described by 
Abramowltz, Iyengar and Blrnbaumer (14). [^^^IJICYP was 
purchased from Amersham International. Propranolol was from 
Ayerst Laboratories Inc., NY. Butanol and glycerol were 
from Fisher Scientific. Acrylamlde and X-ray films (X-Omat 
GBX-2) were purchased from Kodak. N,N,N',N•-
38 
tetranethylethylenediamlne (TEMED), bronophenol blue, 
coomassle blue , N,N'-methylene-bis-acrylamide (BIS) and 
ammonium persulphate were from Bio Rad. The pertussis toxin 
was from List Biochemical Laboratories and the sodium 
dodecyl sulphate (SDS) from BDH Biochemicals. 
Animals New Zealand white rabbits (3.0-4.5 kg) were 
used throughout the study. Pseudopregnancy was induced in 
these rabbits by injecting 0.3 lU porcine FSH 
subcutaneously, twice a day for 3 days followed by 100 lU 
hCG intravenous on the fourth day. On the seventh day after 
the first hCG injection (day zero of pseudopregnancy), the 
animals were either injected with 0.9% saline (control) or 
100 lU hCG (experimental) and killed by cervical dislocation 
at different time periods (0 h, 3 h, 6 h, 12 h, 24 h, and 48 
h). The ovaries were removed and placed in ice-cold Kreb's 
Ringer bicarbonate, pH 7.4, until isolation of corpora lutea 
from the ovaries. The dissected corpora lutea were 
homogenized in ice-cold 27% wt/wt sucrose in 10 mM Tris-HCl, 
1 mM EDTA, pH 7.5, and the membrane particles were prepared 
as described by Birnbaumer et al. (15). 
Adenvlvl Cyclase Assay: Adenylyl cyclase activity 
was determined at 32.5 °C in medium containing 2.5 mM ATP 
(with 20-25 X 10® cpm [alpha-32p]ATP), 3.0 mM MgClg, 1.0 mM 
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EDTA, 1.0 mM cAMP (with approximately 10^ cpm [^H]cAMP), 20 
mM creatine phosphate, 0.2 mg/ml creatine kinase, 0.02 mg/ml 
myokihase and 25 mM Tris-HCl pH 7.5, in the presence or 
absence of either 0.1 mM forskolln, 10 ug/ml oLH, 0.1 mM ISO 
or 10 mM NaF. Assays were carried out for 10 minutes in a 
final volume of 50 ul. The assays were stopped by the 
addition of 100 ul stopping solution containing 10 mM cAMP, 
40 mM ATP, and 1% SDS. The [^^P]cAMP formed and the 
[^H]cAMP added to moniter recovery, were isolated according 
to the method of Salomon et al. (16) using Dowex and alumina 
chromatography as modified by Bockaert et al. (17). All 
experiments were done in triplicates. Protein was 
determined by the method of Lowry et al. (18) using BSA 
(fraction V) as standard. 
Assay for LH/hCG Receptors! iodo-hC6 binding 
assay were carried out in the presence of 5-2000 pM 
jl25ijiodo-hC6, 1.25% BSA, 1.0 mM EDTA, 20 mM Tris-HCl pH 
7.5, with 7-10 ug of membrane protein, in a total volume of 
0.1 ml. Incubations were for 90 minutes at 32.5 °c. The 
nonspecific binding of [^^®I]lodo-hCG to membrane was 
determined by using 50 lU/ml of cold Sigma hCG. The 
reactions are stopped by the addition of 1.5 ml of ice-cold 
0.2% bovine gamma globulin in 0.1 M NaCl, followed by 0.5 ml 
of ice-cold 20% polyethylene glycol (Carbowax 8000). The 
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mixtures were vortexed, left on ice for 10 minutes, and 
centrifuged for 15 minutes at 3000 rpm in a Sorvall RT6000 
centrifuge, at 4 °C. The supernatants were aspirated and 
the pellets were resuspended in 1.5 ml of 0.1 M NaCl and 
then again reprecipitated by addition of 0.5 ml of 20% 
polyethylene glycol. The amount of [^^®I]iodo-hCG bound to 
the precipitates was then determined in a gamma counter 
after centrifugation and aspiration of the supernatant 
fluids. Binding sites and receptor affinity were determined 
by performing Scatchard analysis, both manually and using 
the IBDA/ligand program. Analysis of data by both methods 
gave similar results. 
Assav for beta-adrenergic receptors! [^^^I]ICYP 
binding assays were carried out in the presence of 5-2000 pM 
[125l]ICYP, 0.1% BSA, 1.0 mM EDTA, 25 mM Tris-HCl pH 7.5, 
0.1 mM ascorbic acid, with 8-10 ug of membrane protein, in a 
total volume of 0.5 ml. Incubations were performed for 30 
minutes at 32.5 °C. The nonspecific binding of [l25l]lCYP 
to membrane was determined by using 10 uM of (-)propranolol. 
The reaction was stopped and bound and free ligand was 
separated as described for LH/hCG receptor assay. Binding 
sites and receptor affinity were determined by performing 
Scatchard analysis, both manually and using the IBDA/ligand 
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program. Analysis of data by both methods gave similar 
results. 
Validation pf th? Acid Blwtion Prpcedyre: 
Procedures currently available for the assessment of 
occupied gonadotropin receptors involve the elution of bound 
hormones followed by quantitation of eluted hormone by RIA. 
Although these procedures quantitate the number of occupied 
receptors, they do not assess changes in the receptor which 
may occur upon occupancy by gonadotropin. The following 
procedures developed in our laboratory has enabled us to 
dissociate bound hCG from rabbit luteal membranes and 
allowed for subsequent evaluation of gonadotropin binding. 
Luteal membranes were incubated with 2 nM [^^^I]iodo-
hCG for 90 minutes at 32.5 ®C to occupy the gonadotropin 
receptors. Bound iodo-hCG was eluted by incubation at 
4 °C for periods of time up to 30 minutes in the presence of 
acetic acid at varying pH. The total volume of the 
incubation mixture was 360 ul. The mixture was neutralized 
by the addition of 740 ul of 0.2 M sodium acetate, and the 
membranes were collected by centrifugation at 13,000 x g for 
30 minutes at 4 °C. Decreasing the pH from 7.5 to 3.5 
resulted in a progressive increase in the amount of 
jl25ijiodo-hC6 eluted from the membranes such that at pH 
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3.5, greater than 99% of the specifically bound [^^®I]iodo-
hCG was eluted (Fig lA). Elution of bound hormone at pH 3.5 
was time-dependent such that after 20 minutes of treatment, 
greater than 99% of the gonadotropin was eluted (Fig IB). 
Scatchard analysis of iodo-hCG binding revealed that 
acetic acid treatment at pH 3.5 of control membranes did not 
alter the affinity or concentration of receptors present, 
compared to untreated or neutral washed membranes (Fig 2). 
Aseay t<?r Gg and Ci** 
[32p] ADP-ribose Labeling of sM G^. 
Labeling of Gg and G^ with [^^P]ADP-ribose was done with 
cholera toxin (40 ug/ml) and pertussis toxin (2.5 ug/ml) 
respectively, in 1.5 ml microfuge tubes, in a total volume 
of 100 ul of reaction mixture. The reaction mixture 
contained 1 mM ATP, 0.5 mM GTP, 25 mM Tris-HCl pH 7.5, 5 mM 
DTT, 15 mM thymidine, 5 mM ADP-ribose pH 7.5, 20 mM arginine 
and 14 X 10® cpm of [32p]NAD+; with either 40, 80 or 160 ug 
of luteal membrane protein. The assay was initiated by 
addition of membrane proteins, and incubated at 32.5 °c for 
30 minutes. The assay was stopped by addition of 400 ul of 
ice-cold 10 mM Tris-HCl pH 7.5, 1 mM EDTA; thoroughly 
vortexed and then centrifuged at 13,000 x g for 15 minutes 
at 4 °C. The supernatant was aspirated and the pellet then 
resuspended in 50 ul of sample buffer containing 62.5 mM 
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Tris-HCl pH 6.8, 1% SDS, 10% glycerol, and 5% beta-
mercaptoethanol. Ten microliters of bronophenol blue 
dissolved in 1% glycerol (v/v) and 3.5% sucrose (w/v), was 
added as a tracking dye. The 60 ul of resuspended membrane 
in sample preparation buffer and dye was boiled for 2 
minutes before subjecting the samples to PAGE. 
Molecular Weight Standards Lysozyme of Mr = 
14,400, soybean trypsin inhibitor of Mr = 21,500, carbonic 
anhydrase of Mr = 31,000, ovalbumin of Mr = 45,000, bovine 
serum albumin of Mr = 66,200 and phosphorylase B of Mr = 
92,500, were obtained from Bio-Rad. These molecular weight 
protein standards are in a mixture, which is then dissolved 
in 18 volumes of sample preparation buffer and one part of 
bromophenol blue tracking dye. The standard mixture is then 
boiled for 2 minutes prior to electrophoresis. 
SDS- Polvacrvlamide Gel Electrophoresis The 
samples treated as above were run on a 10% polyacrylamide-
0.2% Bis gel, having a 5% polyacrylamide-0.1% Bis stacking 
gel. The gels had a thickness of 0.75 mm. The 10% 
polyacrylamide was in a solution of 188 mM Tris-HCl pH 8.8, 
0.1% SDS, 0.05% w/w ammonium persulphate and 0.033% TEMED 
was added for polymerization. The stacking gel of 5% 
acrylamide and 0.1% Bis was in a solution of 62.5 mM Tris-
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HCl pH 6.8, 0.1% SDS w/v, 0.1% ammonium persulphate w/w and 
0.05% TEMED. The gels were run in a Tris-Glycine buffer 
with 0.064% SDS. The gels were prerun for 4 hours at a 
constant voltage of 100 V, prior to loading samples. After 
the samples were loaded, they were run at 50 V until the dye 
front was well in to the main gel, which was then run at a 
constant voltage of 100 V for the next 6-7 hours. 
After electrophoresis, the gels were stained over night 
in glacial acetic acid:95% methanol:water (1:5:5) containing 
0.1% coomassie brilliant blue. The following morning, the 
gels were destained in 1:5:5 solution of acetic acid-
methanol and water for 2 hours, followed by a solution 
containing 7.5% glacial acetic acid by vol., 5% of 95% 
ethanol by vol. and 87.5% by vol. of distilled water for 
another 2 hours. Finally the gels were soaked in 0.1% 
glycerol for 2 hours prior to drying. After drying, the 
gels were juxtaposed to Kodak X-Omat 6BX-2 film, which were 
then sandwiched between two intensifying screens. This was 
then placed in a film holder, wrapped in aluminum foil and 
placed in a -70 ®C freezer for 4 days, after which the X-ray 
film was developed. 
The Gg and Gj^ bands in the autoradiograms were then 
scanned by a laser densitometer, to quantitate the extent of 
labeling. Each gel had three protein concentrations of both 
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control and desensitized membranes for one time point. Both 
control and desensitized membranes were on the same gel for 
comparison. The densltometrlc scan value of each band was 
plotted by a chart recorder. All plots were photocopied, 
and each peak was cut out and weighed. The amount of CL 
membrane protein that was loaded on to each well was 
determined by the method of Lowry et al. (18), using BSA 
(fraction V) as standard. The weight of each peak was 
plotted against the amount of CL membrane protein actually 
loaded. The rational behind using three protein 
concentrations for each set of control and desensitized 
membranes, was to make sure that there was a linear 
relationship between extent of labeling and amount of 
protein used in the incubation mixture. In order to be 
within the linear range, the three protein concentrations 
used were approximately 160 ug, 80 ug and 40 ug 
respectively. The extent of labeling was calculated from 
the slopes of traces generated by plotting the three protein 
concentrations verses the weight of the scan. 
S49 Cyc- Cell Culture Cells were grown in Dulbeccos 
Modified Eagle Medium (DMEM), with 10% heat inactivated 
horse serum, containing 100 units/ml of penicillin and 75 
units/ml of streptomycin. Cells were kept at a density of 
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0.75 !- 1 X 10^ cells/ml, and were grown in a 8 liter Bellco 
spinner flask, in an atmosphere of 5% CO2 at 37 °C. The 
cells doubled approximately every 24 hours. 
Membrane Preparation from §49 Çyç- Çglle 
Puck's Saline G Four liters of Puck's Saline G was made 
up fresh before each eye" membrane preparation. 1.6 g of 
KCl, 0.6 g of KH2PO4, 32 g NaCl and 0.61 g Na2HP04 were 
dissolved in 4 liters of deionized double distilled water 
and cooled to 4 °C before use. 
Homoaenlzation Buffer Half a liter of homogenization 
buffer was also freshly prepared for use and cooled to 4 °C 
before use. Homogenization Buffer contained 20 mM Na-Hepes, 
125 mM NaCl, 1.0 mM dithiothreitol (DTT) and 1.0 mM EDTA. 
NaOH at 0.1 N was used to adjust the solution to pH 8.00. 
Cells in DMEM from the 8 liter Bellco spinner flask 
were poured in to 4 x 250 ml centrifuge bottles and spun at 
3,200 rpm for 15 minutes in Sorvall RT6000 centrifuge at 4 
°C, in a Sorvall HIOOO rotor. The supernatant from each 
bottle was carefully discarded in to a bucket containing 
bleach. The cell pellet in each centrifuge bottle was then 
resuspended in 200 ml of Puck's saline G (PSG) at 4 °c. The 
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suspension of cells in PS6 was then spun again at 3,200 rpm 
for 15 minutes in the Sorvall RT6000 centrifuge at 4 °C and 
supernatant discarded. This washing procedure was repeated 
thrice before the cells were suspended in homogenization 
medium (HM). The cells in HM were transferred to a 250 ml 
beaker and placed in a Tare Parr Bomb jar sitting on ice. 
The Parr Bomb was then filled with nitrogen gas until the 
gauge on Parr Bomb read 400 psi. The bomb was let to sit on 
ice at that internal pressure for a 20 minute period. A 250 
ml beaker covered with parafilm, and punctured only to let 
the Parr Bomb nozzle in, was held and the pressure from the 
Parr Bomb slowly let out through the nozzle emptying in to 
the parafilm covered beaker. The 250 ml parafilm covered 
beaker was also set on ice. The lysed cells were then 
collected and diluted with equal amounts of HM. The mixture 
was then poured in to 30 ml centrifuge tubes and spun at 
1000 rpm in a Sorvall RC5 centrifuge for 5 minutes at 4 °C 
in a SS34 rotor. The supernatant was then poured in to 
another 30 ml tube and the pellet discarded. The collected 
supernatant after the first spin was then centrifuged at 
20,000 X g for 30 minutes at 4 °C. The resultant 
supernatant was discarded and the pellet resuspended in two 
volumes of homogenization buffer. The eye" membrane 
suspensions were then aliquoted in 100 ul volumes in to 10 x 
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75 nun test tubes placed in an acetone-dry ice bath, before 
the tubes were capped and stored in a -70 °C freezer. 
Cvc" Reconstitution 
Preparation of luteal membrane cholate extract: 
Cholic acid crystals were dissolved in hot 100% ethanol and 
gradually cooled, resulting in the recrystallization of 
cholic acid. The crystals were then filtered over Whatman # 
2 filter, washed with double distilled water at 4 °C, dried 
and the procedure repeated twice. The cholic acid crystals 
were solubilized and their pH adjusted to 7.5, using IM 
Tris-Base. Finally, the solution was dissolved in 10 mM 
Tris-HCl pH 7.5 and adjusted to a final concentration of 5% 
and stored at 4 ®C. 
Cholate extraction of 1.6 mg of luteal membrane was 
performed by adding Tris-cholate at a final concentration of 
1% cholate in a total extraction mixture volume of 150 ul. 
The mixture was allowed to sit on ice for 30 minutes with 
frequent vortexing prior to centrifugation at 100,000 x g 
for 60 minutes. The clear supernatant enriched in 6g was 
then pipetted in 50 ul aliguots in 10 x 75 mm glass tubes 
sitting in a dry ice-acetone bath. The frozen cholate 
extract was then stored in a -70 °C freezer until assayed. 
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Cvc~ Reconstitution Assay Chelate extracts 
were prepared from CL membranes from individual rabbits 
(both hCG-treated and controls) and a large cholate extract 
prepared from membranes pooled from control rabbits, was 
used as a reference standard during each assay. 
Then 50 ul of 1% cholate extract in each of the three 
tubes (reference standard cholate extract, cholate extract 
of CL membranes from control animals and desensitized 
animals) were incubated for 20 minutes at 32.5 °C to kill 
any contaminating catalytic activity in the extracts. The 
extracts were then diluted five-fold with a ice-cold 
solution containing 0.5 mM ATP, 1.5 mM MgClg ,0.1 mM GTP and 
10 mM Tris-HCl, pH 8.6. Two serial dilutions were made of 
the extract so that each dilution had 0.2% cholate, 0.5 mM 
ATP, 1.5 mM MgClg# 10 mM Tris-HCl pH 8.6 and 0.1 mM GTP. 
Cyc' membranes were diluted so that the mixture contained 
0.5 mM ATP, 1.5 mM MgClj, 0.1 mM GTP and 10 mM Tris-HCl pH 
8.6; with 5 ul of the solution having approximately 15-20 ug 
of cyc~ membrane protein. Five microliters of the £ 
inactivated 0.2% cholate extract at three serial dilutions 
of approximately 3 ug, 1.5 ug and 0.75 ug were preincubated 
for 30 minutes at 4 ®C with a 5 ul solution containing 0.5 
mM ATP, 1.5 mM MgClg, 0.1 mM GTP and 10 mM Tris-HCl pH 8.6, 
with or without eye" membranes. Final assay for cyclase 
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activity in eye" alone, cholate extract alone at three 
serial dilutions and eye" plus cholate extract at three 
serial dilutions, were carried out for 20 minutes at 32.5 °C 
in presence of 0.02% cholate, 20 mM MgCl2, 0.1 mM ATP, 1 mM 
EDTA, 1 mM cAMP, 20 mM creatine phosphate, 0.2 mg/ml 
creatine kinase, 0.1 mM GTP and 0.02 mg/ml myokinase; and 
all, either in presence or absence of 10 mM NaF and or 100 
uM ISO. 
Statistical Analysis A two way analysis of variance 
was performed for the effects of treatment and time, using 
PROC Gin of SAS. Sums of squares were calculated from 
treatment, time and treatment x time interactions, using the 
extra sums of squares responsible. A complete nested design 
with factorial treatment were used, where one factor is time 
and the other is treatment. The Einot-Gabriel multiple 
comparison method was used to determine which means are 
different and the probabilities associated with those pre­
planned comparison. 
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RESULTS 
Adenylyl çyçlag? sptivity in luteal membranes 
Adenylyl cyclase assays were performed as described in 
materials and methods. Table 1 presents a summary of the 
adenylyl cyclase activity in control luteal membranes at 
different time points after intravenously treating rabbits 
with of 0.9% saline. No significant change in the basal, 
oLH, ISO-, NaF- and forskolin-stimulable adenylyl cyclase 
activities are seen with time. oLH-stimulable adenylyl 
cyclase activities are approximately 4 fold and ISO 
stimulable activities 3.5 fold above basal cyclase values 
at all time points. In contrast hCG treatment of rabbits 
resulted in altered adenylyl cyclase activity, as presented 
in Table 2 and Fig 3. Three hours after hCG treatment, 
basal adenylyl cyclase activities are approximately 2.5 fold 
higher than control basal values, and return to control 
values by 24 h. LH stimulable adenylyl cyclase activity in 
luteal membranes from hCG-treated animals show a drop of 41% 
at 6 h and continues to decline until 24 h, when a 67% loss 
in LH-stimulable adenylyl cyclase activity is observed. No 
further decrease is noted at 48 h. ISO stimulation of 
adenylyl cyclase is unaltered until 12h, at which time ISO 
stimulated activity is reduced by 25% and continued to 
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decline to 50% at 24 h, after which there is no change in 
activity. hCG treatment resulted in a 25% depression of 
NaF-stimulable activity at 3 h, after which NaF-stinulable 
activity increased, prior to a time-dependent decrease in 
activity. In contrast, forskolin-stimulable adenylyl 
cyclase activity remained elevated for 12 h, prior to a time 
dependent decrease in activity. 
LH/hCG receptors In control animals, no change in 
number of hCG binding sites were observed until 12 h, after 
which there was a 20-25% decrease in hCG receptor number. 
hCG treatment resulted in a time dependent decrease in the 
number of total and available LM/hCG receptors, such that by 
12 h the number of available LH receptors fell to 2% of 
control while the total number of receptors was 73% of 
control. At 24 h and 48 h the number of total and available 
LH/hCG receptors was only 18% of control as shown in Table 
3, Table 4 and Fig 4. Scatchard analysis of luteal 
membranes from a 12h desensitized rabbit revealed that there 
are two populations of binding sites in these membranes. 
The occupied receptors in these membranes have an affinity 
(Kd = 1.67 nM) approximately 5 times lower than that found 
in controls. The available binding sites have affinities 
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similar to those found in control animals Fig-5 (Kd = 0.3 
nM). 
Beta-adrenergic receptors In control animals, beta-
adrenergic receptor number was unaltered throughout the 
study period, remaining at a concentration of 120 fmol/mg 
membrane protein. In contrast, hCG-induced desensitization 
of the rabbit corpus luteum resulted in loss of beta-
adrenergic receptors, as indicated in Table 5 and Fig 6. In 
hCG desensitized membranes, the loss in beta-adrenergic 
receptor is not evident until 12 h after hCG injection. At 
12 h the number of beta-receotors was decreased by 56% and 
continued to decline to 36% of control values by 24 h, after 
which there was no further decrease. In hCG desensitized 
membranes, there was no change in the affinity of beta-
receptors to [^^®I]iodocyanopindolol until 48 h, at which 
time a 1.7 fold loss in affinity (Kg = 13 pM to Kp = 22 pM) 
was observed. 
Reconstituted adenvlvl cyclase activity 
Reconstituted adenylyl cyclase activities were determined as 
indicated in materials and methods. NaF- and ISO-
reconstituted cyclase activities were found to be linear 
with protein content of cholate extracts, as seen in Fig 7. 
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Both ISO- and NaF-reconstituted activities in controls 
remained unchanged through most of the study period except 
at 48 h, when a 25% drop in activity was observed. On the 
other hand, hCG treatment resulted in a 25% decrease in NaF-
reconstituted activity at 3 h, a 75% increase at 6 h, and a 
return to control levels at 12 h, that was followed by a 55% 
decrease at 24 and 48 h. Similar changes were observed in 
ISO-reconstituted activity at 3 and 6 h. At the 12 h time 
point, ISO-reconstituted activity was depressed by 65% and 
remained at this level for the remainder of the study period 
(Table 6 and Fig 8). Changes in NaF-reconstituted activity 
paralleled changes in NaF-stimulated luteal adenylyl cyclase 
activity (Fig 9). Depressed ISO-reconstituted activity was 
observed at the same time as depressed ISO-stimulated luteal 
adenylyl cyclase activity. 
Bacterial toxin Induced labeling of and Gj-like 
protein Bacterial toxin induced ADP-ribosylation of Gg-
and G^-like substrates in luteal membranes were carried out 
as described in materials and methods. Three identifiable 
cholera toxin substrates: âlfillâs 42, alpha^ 45 and aloha. 
46 and one pertussis toxin substrate alpha^ 40 was seen (Fig 
10). The G^-like pertussis toxin substrate was elevated 50% 
at 3 and 6 h was at control levels at 12 and 24 h, and was 
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depressed by 38% at 48 h. hCG treatment reduced the levels 
of âlfiilâs 45 between 25 and 45% throughout the study period. 
AlBhag 42 was at control levels the first 24 h, then reduced 
36% at 48 h. AlPhag 46 was depressed by 20% at 3, 6 and 24 
h, was at control levels at 12 h and then depressed by 45% 
at 48 h Fig 11. The decreased levels of alpha^ 45 and 
increased levels of G^-like protein, were associated with 
decreased LH-stimulated luteal adenylyl cyclase activity. 
Thus, the alteration of Gg and G^-like protein upon hCG 
treatment may in part be responsible for altered 
responsiveness of the adenylyl cyclase system in the rabbit 
corpus luteum. 
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DISCUSSION 
Hormonal regulation of receptor-adenylyl cyclase system 
and target cell responsiveness to hormonal stimulation has 
been demonstrated In various endocrine target tissues. It 
has frequently been shown that treatment with a hormone is 
followed by subsequent loss of the target cell response to 
the hormone. For example, administration of hCG to rats is 
followed by dlmenlshed steroid responses in the testis (19-
21) or ovary (22) on subsequent rechallenge by hCG. This 
decreased capability of steroid output by the above tissues, 
has been shown to be associated with ah impairment of the 
hormonally responsive adenylyl cyclase of the tissue (23-
32). Studies in pseudopregnant rabbits, have shown that 
injection of an ovulatory dose of hCG, results in luteolysis 
and that this luteolytic effect of hCG is a result of 
desensitlzatlon of the luteal adenylyl cyclase to hCG (23). 
Earlier studies (17) with pig Graafian follicles show that 
desensitlzatlon of the adenylyl cyclase to LH stimulation is 
dependent on Mg2+ and ATP, suggesting that phosphorylation 
of a cyclase component or components may be a factor in 
desensitlzatlon. Further evidence of phosphorylation being 
an event in gonadotropin-Induced cell free desensitlzatlon, 
has come from studies in our laboratory. Rabbit luteal 
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membranes when Incubated in the presence of 2.5 mM ATP and 
LH for 30 minutes under conditions which will support 
phosphorylation, results in reduced adenylyl cyclase 
activity on LH rechallenge. Studies using rat luteal cells 
in culture (33) indicate that desensitization of the 
adenylyl cyclase after hC6 treatment, occurs with rapid loss 
of LH-stimulable activity and a delayed recovery in unison 
with the return of LH receptors. The initial rapid loss in 
LH-responsiveness precedes the decrease in total (occupied + 
free) LH receptors. In these studies, the LH receptors were 
at their lowest concentration on the second day after hCG 
treatment, and returned to control values on the seventh day 
after treatment. On the other hand, there was no change in 
beta-adrenergic receptor content in hCG-desensitized cells, 
although an early loss in epinephrine-stimulable cyclase 
activity was seen. Therefore, these studies in rat luteal 
cells indicate that gonadotropin-induced desensitization 
results initially in adenylyl cyclase refractoriness, 
without loss of LH receptors. Loss in LH- and 
catecholamine-stimulable responses, without loss in beta-
adrenergic receptors, suggests alteration in the coupling 
mechanism of the cyclase system to heterologous ligands. 
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In the present study, several changes at the LH/hC6 and 
beta-adrenergic receptor level as well as at the level of 
the transducing proteins and catalytic moiety of the 
adenylyl cyclase system were seen. The acid elution study 
enabled us to identify total and available LH/hC6 binding 
sites on luteal membranes at different desensitized time 
points and to determine changes in affinity of the LH/hCG 
receptor to its agonist on desensitization. 
The high basal adenylyl cyclase activity (2.5 fold) in 
luteal membranes from hCG-treated rabbits, could be due to 
stimulation of the cyclase system by irreversibly bound hCG 
to membrane receptors. Earlier studies (23) in CL of 
pregnant and pseudopregnant rabbits, also show similar 
results. The 25-30% loss in LH/hCG receptors at 3 h and 6 h 
time points, coincides with the loss in LH-stimulable 
adenylyl cyclase activity, since no change in ISO 
stimulable adenylyl cyclase activity or beta-adrenergic 
receptor number was seen until 12 h, where as LH-stimulable 
adenylyl cyclase activity as well as loss in LH/hCG receptor 
number were seen, it is evident that until 12 h, we see 
homologous desensitization of the adenylyl cyclase system in 
this tissue after which the desensitization is heterologous. 
The loss in ISO stimulable adenylyl cyclase activity in 
rabbit luteal membranes 12 h post injection of hCG, 
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coincides with loss of beta-receptors. These observations 
indicate that ISO-stimulable loss in adenylyl cyclase 
activity in this system is due in part to loss of beta-
receptors. The loss of LH/hCG stinulable activity could not 
only be due in part to receptor loss but also due to the 
decrease in affinity of the LH/hCG receptor to its agonist. 
Part of the initial elevated levels of forskolin-stimulable 
adenylyl cyclase activity could have been due to an 
increased activity in the transducing protein that is seen 
earlier in the desensitization process. It is also very 
likely, that at later time points, there is internalization 
and/or inactivation of the transducing proteins as well as 
the catalytic moiety, together with the LH/hCG and beta-
receptors. 
Recently, it has been reported that there is a beta-
receptor protein kinase (beta-RPK) in the cytoplasm of frog 
erythrocytes, which is translocated to the membrane on 
occupancy of the beta-adreneraic receptor with its agonist 
(34,35). The kinase is responsible for phosphorylating the 
agonist-occupied receptor which then leads to receptor 
desensitization and down regulation. In the rabbit luteal 
tissue, it is likely that there is a nonspecific-receptor 
protein kinase, which phosphorylates specifically occupied 
receptor and nonspecifically unoccupied receptors. So on 
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hCG occupancy of its receptor, there is a rapid 
phosphorylation of the occupied raceptors by the receptor 
kinase, leading to decreased affinity of LH/hCG receptor to 
agonist and a slow nonspecific phosphorylation of available 
beta-adrenergic receptors, leading to heterologous 
desensitization and down regulation. 
hCG treatment also alters the ability of luteal cholate 
extracts to reconstitute NaF- and ISO-stimulated adenylyl 
cyclase activity in S49 eye' membranes. There is clearly a 
dissociation of the NaF-? and ISO-reconstituted activity, as 
indicated by the preferential loss of ISO-reconstituted 
activity following hCG treatment (Fig-5). This finding is 
supportive of the fact that the alpha subunit of Gg has 
different sites for NaF-stimulable activity and receptor 
coupling, and that in this case the beta-adrenergic receptor 
coupling domain of alpha Gg is altered prior to alteration 
of the NaF-stimulating site. Parallel changes in NaF-
stimulated adenylyl cyclase activity following hCG treatment 
(Fig-6), suggests that changes in Gg may be responsible for 
the altered response of the cyclase system to NaF. Earlier 
studies in highly luteinized rat ovaries show that hCG 
Induced heterologous desensitization of adenylyl cyclase 
results in attenuation of Gg activity by approximately 35% 
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as assessed by eye- reconstitution, regardless of the 
stimulatory ligand used (9). 
The decreased level of and the increased 
levels of were associated with decreased LH-
stimulable adenylyl cyclase activity. The preferential 
depression in the ability of aiBhas45 to be ADP-ribosylated 
by cholera toxin following hCG treatment suggests that there 
may be preferential interaction of the LH/hCG receptor with 
this isomorph of alpha Gg. 
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Fig lA: Elution efficiency of iodo-hCG bound to 
rabbit corpus luteum membranes by acetic acid. 
Acid treatments were carried out at 4 °C for a 
period of 20 minutes. These results indicate a 
greater than 99% elution of bound hormone from 
membranes treated with acetic acid at pH 3.5 
Fig IB: Elution of membrane-bound [^^^I]iodo-hC6 by acetic 
acid (pH 3.5), as a function of time. Incubation 
of membranes with acid was carried out on ice. 
The acid treatment resulted in a time dependent 
increase in elution of bound iodo-hCG from 
membranes, such that after 20 minutes, there is 
greater than 99% elution of bound gonadotropin 
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Fig 2: Scatcherd analysis of rabbit corpus luteum 
membranes that were (a) not treated, (b) subjected 
to a neutral wash with Na-acetate buffer and (c) 
treated with acetic acid at pH 3.5. All 
treatments were carried out on ice for 20 minutes. 
These binding studies indicate that acid treatment 
had no effect on the affinity or concentration of 
LH/hCG receptors 
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Table 1 Summary of adenylyl cyclase activity in control 
luteal membranes from the hC6 protocol^ 
Time After Control 
Treatment oLH® ISO* NaF® 
pmole/min" Vnig" ^ 
3h Mg 
SD" 
33** 
±8 
129 
±16 
107 
±20 
567** 
±35 
562 
±130 
6h 26* 
±6 
133* 
±13 
91 
±15 
297* 
±15 
457 
±56 
12h 32* 
±8 
113* 
±26 
98* 
±13 
411 
±73 
548 
±76 
24h 30 
±4 
99** 
±25 
97* 
±26 
386* 
±29 
579 
±172 
48h 30 
±5 
115** 
±36 
105* 
±22 
509** 
±128 
742' 
±272 
^Rabbit luteal membranes were incubated as outlined in 
Materials and Methods, in the presence and absence of oLH, 
ISO, NaF and forskolin, for 10 minutes at 32.5 °C. The 
concentration of membrane was 5-10 ug/50 ul assay. Adenylyl 
cyclase activity is expressed as the amount of [^^P]cAMP 
formed from added [alBha- P]ATP. Values are mean +SD of 
assays from four separate animals at each time point. 
Each assay was done in triplicates. 
= Basal cyclase activity. 
°LH = Luteinizing hormone stimulable cyclase activity. 
ISO = Isoproterenol stimulable cyclase activity. 
' ®NaF = Sodium fluoride stimulable cyclase activity. 
F = Forskolin stimulable cyclase activity. 
9m = Mean. 
^SO = Standard deviation. 
Significantly different from desensitized (p<0.01). 
Significantly different from desensitized (p<0.001). 
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Table 2 Summary of adenylyl cyclase activity In luteal 
membranes from hC6 treated rabbits^ 
Time after hCG-Treated 
Treatment Bb oLH® ISO* NaF® F^ 
pmole/min~Vrog -1 
3h Mg 88** 122 108 374** 627 
SD" ±21 ±35 ±37 ±17 ±176 
6h 56* 80* 96 444* 654 
±9 ±17 ±10 ±13 ±166 
12h 53* 65* 76* 417 723 
±16 ±13 ±13 ±69 ±169 
24h 29 36** 51* 265* 386** 
• ±5 ±11 ±11 ±50 ±111 
48h 31 39** 43* 228** 296** 
±10 ±12 ±12 ±78 ±70 
^Rabbit luteal membranes were incubated as outlined in 
Materials and Methods, in the presence and absence of oLH, 
ISO, NaF and forskolin, for 10 minutes at 32.5 °c. The 
concentration of membrane was 5-10 ug/50 ul assay. Adenylyl 
cyclase activity is expressed as the amount of [^^P]cAMP 
formed from added [ailÉa- P] ATP. Values are mean +SD of 
assays from four separate animals at each time point. 
Each assay was done in triplicates. 
= Basal cyclase activity. 
°LH = Luteinizing hormone stimulable cyclase activity. 
ISO = Isoproterenol stimulable cyclase activity. 
®NaF = Sodium fluoride stimulable cyclase activity. 
F = Forskolin stimulable cyclase activity. 
®M = Mean. 
^SD = Standard deviation. 
Significantly different from control (p<0.01). 
Significantly different from control (p<0.001). 
Effects of hC6 treatment on luteal adenylyl 
cyclase activity. Note the different responses of 
LH-, ISO-, NaF- and forskolin-stimulated adenylyl 
cyclase activities to hCG treatment. Values were 
calculated by dividing the mean adenylyl cyclase 
activity from hCG-treated animals by the mean 
adenylyl cyclase activity from control animals and 
the result multiplied by 100 
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Table 3 Summary of Scatchard analysis of [^^®I]iodo hCG 
binding to neutral washed luteal membranes from 
control and hCG-treated rabbits^ 
Time After Control hCG-Treated 
Treatment 
®MAX ®MAX 
(fmol/mg) (pM) (fmol/mg) (pM) 
3h M^ 783 533 537* 458 
SD® ±104 ±119 ±90 ±150 
6h 633 420 515** 446 
±208 ±121 ±61 ±42 
12h 608 428 25*** ND 
±11 ±138 ±7 
24h 567 424 145** 514 
±67 ±184 ±35 ±234 
48h 503 438 164** 380 
±126 ±130 ±60 ±192 
^Rabbit luteal membranes were incubated, as outlined in 
Materials and Method, in the presence of varying 
concentrations of [^^^I]iodo hCG. The membrane 
concentration was 7-10 ug/lOO ul assay. Specific binding 
was the difference between the total [^^^Ijiodo hCG 
precipitated after incubation in the absence and presence of 
excess hCG. Each value represents mean ± SD of four 
separate animals at each time point. 
^ = mean. 
°SD = standard deviation. 
ND = not determinable. 
Significantly different from controls (p<0.05). 
significantly different from controls (p<0.00l). 
Significantly different from controls (p<0.0001). 
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Table 4 Summary of Scatchard analysis of [^^^I]lodo hCG 
binding to acid washed luteal membranes from control 
and hCG-treated rabbits^ 
Time After Control hCG-Treated 
Treatment 
®MAX KD ®MAX KD 
(fmol/mg) (pM) (fmol/mg) (pM) 
3h M^ 785 504 563** 453 
SD° ±49 ±150 ±123 ±152 
6h 838 497 630* 426 
±31 ±180 ±72 ±78 
12h 694 347 490* 1402** 
±169 ±49 ±133 ±279 
24h 604 373 73** 442 
±135 ±80 ±12 ±81 
48h 616 356 106** 310 
±96 ±84 ±28 ±93 
^Rabbit luteal membranes were incubated, as outlined in 
Materials and Method, in the presence of varying 
concentrations of [^^®I]iodo hCG. The membrane 
concentration was 7-10 ug/100 ul assay. Specific binding 
was the difference between the total [^^°I]iodo hCG 
precipitated after incubation in the absence and presence of 
excess hCG. Each value represents mean ± SO of four 
separate animals at each time point. 
^ = mean. 
°SD = standard deviation. 
Significantly different from controls (p<0.05). 
Significantly different from controls (p<0.001). 
Total and available LH/hC6 binding sites In luteal 
membranes of control and desensitized rabbits. 
New Zealand white rabbits were Injected l.v. with 
either 100 lU hCG (to Induce desensltlzatlon) or 
0.9% saline (controls) on the seventh day of 
pseudopregnancy, and killed at the Indicated time 
Intervals after Injection. Four control and four 
desensitized animals were killed for each time 
point, their corpora lutea were dissected, and 
plasma membranes prepared. Membranes were 
subjected to either acid elutlon or neutral wash 
prior to Scatchard analysis of lodo-hCG 
binding. Available binding sites are determined 
In untreated membranes, and the total binding 
sites determined on membranes treated with acetic 
acid at pH 3.5 for 20 minutes 
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Fig 5; Scatchard analysis of luteal membranes from a 12h 
control and a hCG-treated rabbit. The membranes 
were subjected to a 20 minute acid treatment at pH 
3.5, prior assessment of C^^®I]lodo-hCG binding 
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Table 5 Summary of Scatchard analysis of (-)-3-
[I25i] j^odocyanoplndolol binding to control and hCG 
treated rabbit luteal membrane^ 
Time After Control Epinephrine 
Treatment Treatment 
®MAX KD ®MAX KD 
(fmol/mg) (pM) (fmol/mg) (pM) 
3h 120 11 101 11 
SD° ±11 ±3 ±29 ±0.4 
6h 125 12 121 14 
±60 ±4 ±30 ±3 
12h 133 13 59* 9 
±33 ±1 ±10 ±0.2 
24h 120 12 43* 16 
±18 ±3 ±13 ±5 
48h 108 13 39* 22* 
±23 ±1 ±11 ±4 
^Rabbit luteal membranes were incubated with varying 
concentrations of [^^^I]ICYP as outlined in Materials and 
Methods. The concentration of membrane was 8-10 ug/500 ul 
assay. All assays were carried out in the absence and 
presence of 10 uM (-)propranolol. Specific binding was the 
difference between total [^^®I]ICYP precipitated in absence 
and presence of excess (-)propranolol. Values are mean +SD 
of four separate animals at each time point. 
= mean. 
°SD = standard deviation. 
Significantly different from controls (p<0.001). 
Fig 6: Effect of hCG treatment on beta-adrenergic 
receptor content in rabbit corpora lutea. Rabbits 
on the seventh day of pseudopregnanoy, were 
treated with either an i.v. injection of 100 lU 
hCG or 0.9% saline (controls), and killed at the 
indicated time intervals. Corpora lutea were 
disected, and plasma membrane prepared. Beta-
adrenergic receptor content of luteal membranes 
from both control and desensitized animals were 
guaotitated by direct Scatchard analysis of 
[i25j]jcYP binding. Note that, the time dependent 
loss of bsta-adrenergic receptors is similar to 
the time dependent loss of isoproterenol-
stimulable adenylyl cyclase activity after hCG 
treatment 
81 
Rabbit CL 
140i 
5 120-
Control 
100 
40- hCG 
20-
36 0 24 48 12 
Time After Treatment (h) 
Fig 7: Reconstituted NaF- and ISO-stinulable adenylyl 
cyclase activities at three serial dillutions of 
chelate extracts from a 24 h control and 24 h 
desensitized rabbit luteal membranes. Data shown 
are the mean triplicate determinations. This 
demonstrates the linearity in reconstituted 
cyclase activity observed in all reconstituted 
experiments. 
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Table 6 Summary of ISO- and NaF-reconstltuted adenylyl 
cyclase activity in control and hCG-treated rabbits^ 
Time After Control hCG-Treated 
Treatment NaF^ ISO® NaF^ ISO® 
pmole/mg"V20 min"^ 
3h M^ 1073 404 758* 235** 
SD® ±59 ±10 ±75 ±18 
6h 787 350 1300** 619** 
±105 ±94 ±66 ±13 
12h 996 403 1049 125** 
±70 ±5 ±300 ±41 
24h 895 360 409** 124* 
±35 ±13 ±40 ±14 
48h 655 226 355* 70** 
±130 ±19 ±52 
^Chelate extracts of luteal membranes from four control 
and four hCG-treated rabbits for each time point, were 
pooled separately. The pooled chelate extracts were then 
reconstituted into eye" membranes, as indicated in Materials 
and Methods. Values are the mean ± SD of three separate 
assays, each assay done in triplicates. 
^NaF = sodium fluoride reconstituted cyclase activity. 
®ISO = isoproterenol reconstituted cyclase activity. 
°M = mean. 
®SD = standard deviation. 
Significantly different from controls (p<0.01). 
Significantly different from controls (p<0.0001). 
Fig 8: Effects of hC6 treatment on ISO- and NaF-
reconstituted adenylyl cyclase activity. Note a 
dissociation of the NaF- and ISO-reconstituted 
activity as seen by the preferential loss of ISO-
reconstituted activity following hC6 treatment. 
Values were calculated by dividing the mean 
adenylyl cyclase activity from hCG-treated animals 
by the mean adenylyl cyclase activity from control 
animals and the result multiplied by 100 
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Fig 9: Effects of hCG treatment on NaF-stimulated luteal 
adenylyl cyclase activity and NaF-reconstituted 
activity of cholate extracts in S49 eye" 
membranes. Both activities are expressed as 
percent of control activity. Note the parallel 
changes in both activities. Values were 
calculated by dividing the mean adenylyl cyclase 
activity from hCG-treated animals by the mean 
adenylyl cyclase activity from control animals and 
the result multiplied by 100 
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Fig 10: Cholera and pertussis toxin mediated AOP-
ribosylation of rabbit luteal membranes. 
Membranes were incubated in presence of 15 uM 
[^^P]NAD and with or without 40 ug/ml cholera or 
2.5 ug/ml of pertussis toxin. Labeled membranes 
were subjected to SDS-PAGE and autoradiography 
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Fig 11: Effects of hC6 treatment on the extent of ADP-
ribosylation of three aloha Gg isomorphs and aloha 
Gj^ by cholera and pertussis toxin respectively. 
Note the depressed levels of alpha^ 45 throughout 
the study period post treatment 
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SECTION II EPINEPHRINE-INDUCED DESENSITIZATION OF THE 
RABBIT LUTEAL ADENYLYL CYCLASE IS HETEROLOGOUS 
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ABSTRACT 
It is well established that the corpus luteum In 
rabbits contain an adenylyl cyclase that is responsive to 
both LH/hCG and catecholamines (1-4) and both hormones 
activate the same adenylyl cyclase (3,4). Earlier studies 
have shown that exposure of corpora lutea or ovarian tissues 
to either LH/hC6 or catecholamines, lead to refractoriness 
of adenylyl cyclase in that tissue (5,6), and that this 
refractoriness is in part reflective of changes and or loss 
in receptor function (7,8). 
Previous studies from our laboratory indicate that hCG-
induced desensitization of rabbit luteal adenylyl cyclase is 
heterologous and is associated with loss of both LH and 
bsta-adrenergic receptors, as well as altered G-protein 
function, with preferrential loss in activity of one 
isomorph of alpha^ falpha^ 45). In order to compare beta-
agonist induced desensitization in this tissue, rabbits in 
mid pseudopregnancy were treated with either saline or 2.5 
mg/Kg body weight of epinephrine, and euthenized 1.5, 3, 6, 
12, 24 and 48 h post treatment. Luteal membranes were 
prepared and stored at -70 °C for examination. Cyclase 
activity in rabbit luteal membranes from control (0.9% 
saline s.c) and desensitized (2.5 mg epinephrine/Kg s.c.) 
animals was determined in the presence and absence of ISO, 
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oLH, NaF and forskolin. Both beta-adrenergic receptors and 
LH/hC6 receptors were assessed by Scatchard analysis. Total 
and available LH/hCG receptors were quantitated and analyzed 
for each time point by help of an acid elution procedure 
that was developed for this purpose earlier. Changes in Gg 
activity were assessed by the ability of cholate extracts of 
luteal membranes to reconstitute NaF- and ISO-stimulable 
adenylyl cyclase activity in S49 eye- membranes. Changes in 
Gg and G^-like protein were determined by utilizing the 
ability of cholera toxin and pertussis toxin to ADP-
ribosylate the alpha subunits of Gg and G^-like protein 
respectively. Epinephrine treatment resulted in similar 
changes in ISO-, LH- and NaF-stimulated adenylyl cyclase 
activity, indicating heterologous desensitization. At 1.5 h 
LH-, ISO- and NaF- stimulable adenylyl cyclase activities 
were depressed by 24 to 30% and continued to decline until 6 
h when stimulable adenylyl cyclase activities were depressed 
by 45 to 52%. In contrast, forskolin stimulable cyclase 
activity remained at almost control levels at 1.5 h, but was 
depressed by 30% at 3 h and continued to decline until 6 h, 
when forskolin stimulable adenylyl cyclase activity was 
depressed by 45%. LH-, ISO-, NaF- and forskolin-stimulated 
adenylyl cyclase activities then increased such that by 24 
h, values were at control levels. Epinephrine treatment 
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also resulted in loss of beta-adrenergic receptors which 
paralleled loss in isoproterenol-stimulated adenylyl cyclase 
activity. The affinity of the available beta-adrenergic 
receptors was reduced by 2 and 1.5 fold at 1.5 and 3 h 
respectively, after which the affinity returned to control 
levels. No significant change in total and available LH/hCG 
receptor number in control and desensitized membranes was 
seen. There was approximately a 2 fold drop in LH/hCG 
receptor affinity at early time points (1.5 h to 12 h). 
NaF- and ISO-reconstituted Gg activities were depressed by 
60 to 65% 1.5 h after treatment and remained at these levels 
for 6 h, after which both NaF- and ISO-reconstituted 
activities increased such that by 24 h they were at control 
levels. At 1.5 h after epinephrine treatment, the ability 
of alphag 46 to be ADP-ribosylated by CT"*" was reduced by 
almost 50% in comparison to controls. The ability of aloha. 
46 to be ADP-ribosylated remained depressed until 6 h after 
which ADP-ribosylable activity returned to control levels. 
There was also a 15-25% drop in the ability of alpha^ 45 to 
be ADP-ribosylated by CT"^ during 1.5 h - 12 h after which 
ADP-ribosylable activities returned to control levels. No 
change in the ability to ADP-ribosylate alpha^ 42 and alpha^ 
40 was observed. Therefore, these studies indicate that 
epinephrine-induced desensitization of the rabbit luteal 
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adenylyl cyclase is heterologous. These studies also 
indicate that loss of isoproterenol responsiveness seen 
after epinephrine treatment is due in part to a decrease in 
both hsta-adrenergic receptor number, an early loss of beta-
receptor affinity and altered 6 protein function. The 
preferential loss in the ability of alpha^ 46 to be ADP-
ribosylated by CT"*" following epinephrine treatment, suggests 
that there may be preferential interaction of the beta-
adrenergic receptor with this isomorph of Gg. The similar 
time frame in loss of LH/hCG receptor affinity and depressed 
alphag 45, suggests that there may be preferential 
interaction of the LH/hCG receptor with this isomorph of Gg. 
This strengthens the argument for such an interaction, as 
discussed earlier in section I of the thesis. The loss in 
LH-stimulable adenylyl cyclase activity on epinephrine 
treatment is due in part to altered Gg activity and loss in 
receptor affinity. 
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INTRODUCTION 
Earlier studies using frog erythrocytes (9) and ovarian 
tissue (6) indicate that prolonged exposure to beta-
adrenergic agonists like isoproterenol and epinephrine, 
leads to desensitization of the beta-adrenergic receptor 
coupled adenylyl cyclase system in these tissues. 
Desensitization of beta-adrenergic receptor-coupled adenylyl 
cyclase system in some cases appears to be specific, i.e., 
'homologous* and in other cases is 'heterologous' in nature. 
Homologous desensitization of the adenylyl cyclase system 
that has been observed both in frog erythrocytes (10-13) and 
other cell lines (14,15) demonstrate two different 
alterations in the hs&a-adrenergic receptor properties: one 
being the uncoupling of the receptor from the adenylyl 
cyclase system and the other of receptor down regulation. 
These two processes are also temporally separable. Studies 
using frog erythrocytes also indicate that catecholamine-
induced desensitization of this tissue results in 
internalization of 50% of the beta-adrenergic receptors. 
The internalized receptors are sequestered in vesicles, 
in the absence of either the nucleotide regulatory protein 
or the catalytic unit of the adenylyl cyclase (9). The 
molecular mechanism of desensitization of beta-adrenergic 
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receptor coupled adenylyl cyclase system has yet to be 
deciphered. Recent studies (16,17) In S49 mouse lymphoma 
cells and DDT, MF-2 hamster smooth muscle cells indicate 
that hs&a-adrenerglc receptors are phosphorylated on agonist 
occupancy by a cytoplasmic receptor kinase, which Is 
translocated to the membrane on receptor occupancy. 
Phosphorylation of the hsta-receptor by this kinase is 
thought to be responsible for initiating desensitization and 
receptor down regulation (16,17). 
The corpus luteum in rabbits contains an adenylyl 
cyclase system that is coupled to both LH and beta-
adrenergic receptors, and both LH and beta-adrenergic 
agonists stimulate the system. Earlier studies in our 
laboratory indicate that hCG-induced desensitization of 
rabbit luteal adenylyl cyclase is heterologous and is 
associated with the loss and alteration of both LH and beta-
adrenergic receptors as well as altered G protein function. 
Therefore in order to understand epinephrine Induced 
desensitization of this tissue, studies were carried out to 
examine alterations not only at both receptor levels (LH and 
b&ka-adrenergic) but also at the level of their guanine 
nucleotide binding transducing proteins and the catalytic 
moiety of the adenylyl cyclase system. Results of this 
study show that epinephrlne-lnduced desensitization of 
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rabbit luteal adenylyl cyclase Is heterologous, like hCG-
Induced desensitlzatlon of the tissue, and that loss in 
adenylyl cyclase responsiveness to LH and isoproterenol is 
due in part to altered 6 proteins and loss in number and 
affinity of beta-adrenergic receptors. 
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MATERIALS AND METHODS 
Material Inorganic was purchased from 
International Chemical and Nuclear Corp. (Irving, CA). 
[^H]cAMP (10-20 Cl/mMol) was from Schwarz/Mann (Orangeburg, 
NY). ATP, EDTA, Trls, dlsodium creatine phosphate, creatine 
phosphoklnase, myoklnase, human chorionic gonadotropin 
(hCG), porcine follicle stimulating hormone (FSH), cholera 
toxin (CT"*"), hala-mercaptoethanol, guanosine triphosphate 
(GTP), dithiotreitol (DTT), thymidine, ADP-rlbose, 
epinephrine and arginine were from Sigma Chemical Co. (St. 
Louis, HO). Forskolln was from Calbiochem (LaJolla, CA). 
Ovine LH (oLH) was from NIH, lot # oLH-23, AFP4570-B. (-) 
Isoproterenol was from Sterling-Winthrop Research Institute, 
Rensselaer, NY. [alpha-^^PJATP (SA,>50 Ci/mmol) was 
synthesized according to the procedure of Walseth and 
Johnson (18). [^^PJNAD"*" was synthesized according to the 
procedure of Cassel and Pfeuffer (19). hCG was 
radoiodinated to [^^®I]iodo-hCG by a procedure described by 
Abramowitz, Iyengar and Blrnbaumer (3). [^2®I]ICYP was 
purchased from Amersham International. Propranolol was from 
Ayerst Laboratories Inc., NY. Butanol and glycerol were 
from Fisher Scientific. Acrylamide and X-ray films (X-Omat 
GBX-2) were purchased from Kodak. N,N,N',N'-
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tetraxnethylethylenedlamlne (TEMED), bromophenol blue, 
coomassle blue, N,N'-methylene-bls-acrylamide (BIS) and 
ammonium persulphate were from Bio Rad. The pertussis toxin 
was from List Biochemical Laboratories and the sodium 
dodecyl sulphate (SDS) from BDH Biochemicals. 
Animals New Zealand white rabbits (3.0-4.5 kg) were 
used throughout the study. Pseudopregnancy was induced in 
these rabbits by injecting 0.3 lU porcine FSH 
subcutaneously, twice a day for 3 days followed by 100 lU 
hCG intravenous on the fourth day. on the seventh day after 
the first hCG injection (day zero), the animals were either 
injected s.c. with 0.9% saline (control) or 2.5 mg/Kg 
epinephrine (experimental) and euthanized by cervical 
dislocation at different time periods (1.5 h, 3 h, 6h, 12 
h, 24 h, and 48 h). The ovaries were removed and placed in 
ice-cold Kreb's Ringer bicarbonate, pH 7.4, until isolation 
of corpora lutea from the ovaries. The dissected corpora 
lutea were homogenized in ice-cold 27% wt/wt sucrose in 10 
mM Tris-HCl, 1 mM EDTA, pH 7.5, and the membrane particles 
were prepared as described by Birnbaumer et al. (l). 
Adenvlvl Cyclase Assay Adenylyl cyclase activity 
was determined at 32.5 °C in medium containing 2.5 mM ATP 
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(with 20-25 X 10® cpm [alpha-^^PJATP), 3.0 mM MgClj, 1.0 mM 
EDTA, 1.0 mM CAMP (with approximately 10^ cpm [^H]cAMP), 20 
mM creatine phosphate, 0.2 mg/ml creatine kinase, 0.02 mg/ml 
myokinase and 25 mM Tris-HCl pH 7.5, in the presence or 
absence of either 0.1 mM forskolin, 10 ug/ml oLH, 0.1 mM ISO 
or 10 mM NaF. Assays were carried out for 10 minutes in a 
final volume of 50 ul. The assays were stopped by the 
addition of 100 ul stopping solution containing 10 mM cAMP, 
40 mM ATP, and 1% SDS. The [^^P]cAMP formed and the 
[^H]cAMP added to moniter recovery were isolated according 
to the method of Salomon et al. (20) using Dowex and alumina 
chromatography as modified by Bockaert et al. (21). All 
experiments were done in triplicates. Protein was 
determined by the method of Lowry et al. (22) using BSA 
(fraction V) as standard. 
Assay for LH/hCG Receptors []iodo-hCG binding 
assay were carried out in the presence of 5-2000 pM 
[125l]iodo-hCG, 1.25% BSA, 1.0 mM EDTA, 20 mM Tris-HCl pH 
7.5, with 7-10 ug of membrane protein, in a total volume of 
0.1 ml. Incubations were for 90 minutes at 32.5 °C. The 
nonspecific binding of [^^®I]iodo-hCG to membrane was 
determined by using 50 lU/ml of cold Sigma hCG. The 
reactions are stopped by the addition of 1.5 ml of ice-cold 
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0.2% bovine gamma globulin in 0.1 M NaCl, followed by 0.5 ml 
of ice-cold 20% polyethylene glycol (Carbowax 8000). The 
mixtures were vortexed, left on ice for 10 minutes, and 
centrifuged for 15 minutes at 3000 rpm in a Sorvall RT6000 
centrifuge, at 4 °C. The supernatants were aspirated and 
the pellets were resuspended in 1.5 ml of 0.1 M NaCl and 
then again reprecipitated by addition of 0.5 ml of 20% 
polyethylene glycol. The amount of [^^®I]iodo-hCG bound to 
the precipitates was then determined in a gamma counter 
after centrifugation and aspiration of the supernatant 
fluids. Prior to [^^^I]iodo-hCG binding assays, both 
control and treated membranes were either acid- or neutral-
washed, as described in section I. Binding sites and 
receptor affinity was determined by performing Scatchard 
analysis, both manually and using the IBDA/ligand program. 
Analysis of data by both methods gave similar results. 
Assay for beta-adrenergic receptors [^^^I]ICYP 
binding assays were carried out in the presence of 5-2000 pM 
[125i]icYP, 0.1% BSA, 1.0 mM EDTA, 25 mM Tris-HCl pH 7.5, 
0.1 mM ascorbic acid, with 8-10 ug of membrane protein, in a 
total volume of 0.5 ml. Incubations were performed for 30 
minutes at 32.5 °C. The nonspecific binding of [^^®I]ICYP 
to membrane was determined by using 10 uM of (-)propranolol. 
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The reaction was stopped and bound and free llgand was 
separated as described for LH/hCG receptor assay. Binding 
sites and receptor affinity was determined by performing 
Scatchard analysis, both manually and using the IBDA/llgand 
program. Analysis of data by both methods gave similar 
results. 
Aeeay fpr Gg ana gi 
[32p] ADP-rih9B9 Labeling <?t Gg and 
Labeling of Gg and with [^^P]ADP-rlbose was done with 
cholera toxin (40 ug/ml) and pertussis toxin (2.5 ug/ml) 
respectively, in 1.5 ml microfuge tubes, in a total volume 
of 100 ul of reaction mixture. The reaction mixture 
contained 1 mM ATP, 0.5 mM GTP, 25 mM Trls-HCl pH 7.5, 5 mM 
DTT, 15 mM thymidine, 5 mM ADP-rlbose pH 7.5, 20 mM arginine 
and 14 X 10® cpm of [^^P]NAD"^; with either 40, 80 or 160 ug 
of luteal membrane protein. The assay was initiated by 
addition of membrane proteins, and incubated at 32.5 °C for 
30 minutes. The assay was stopped by addition of 400 ul of 
ice-cold 10 mM Trls-HCl pH 7.5, 1 mM EDTA; thoroughly 
vortexed and then centrifuged at 13,000 x g for 15 minutes 
at 4 °c. The supernatant was aspirated and the pellet then 
resuspended in 50 ul of sample buffer containing 62.5 mM 
Trls-HCl pH 6.8, 1% SDS, 10% glycerol, and 5% beta-
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mercaptoethanol. Ten micro liters of bromophenol blue 
dissolved in 1% glycerol (v/v) and 3.5% sucrose (w/v), was 
added as a tracking dye. The 60 ul of resuspended membrane 
in sample preparation buffer and dye was boiled for 2 
minutes before subjecting the samples to PAGE. 
Molecular Weight Standards Lysozyme of Mr = 
14,400, soybean trypsin inhibitor of Mr = 21,500, carbonic 
anhydrase of Mr « 31,000, ovalbumin of Mr - 45,000, bovine 
serum albumin of Mr <• 66,200 and phosphorylase B of Mr = 
92,500, were obtained from Bio-Rad. These molecular weight 
protein standards are in a mixture, which is then dissolved 
in 18 volumes of sample preparation buffer and one part of 
bromophenol blue tracking dye. The standard mixture is then 
boiled for 2 minutes prior to electrophoresis. 
SDS- Polvacrvlamide Gel Electrophoresis The 
samples treated as above were run on a 10% polyacrylamide-
0.2% Bis gel, having a 5% polyacrylamide-0.1% Bis stacking 
gel. The gels had a thickness of 0.75 mm. The 10% 
polyacrylamide was in a solution of 188 mM Tris-HCl pH 8.8, 
0.1% SDS, 0.05% w/w ammonium persulphate and 0.033% TEMED 
was added for polymerization. The stacking gel of 5% 
acrylamide and 0.1% Bis was in a solution of 62.5 mM Tris-
HCl pH 6.8, 0.1% SDS w/v, 0.1% ammonium persulphate w/w and 
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0.05% TEMED. The gels were run in a Tris-Glycine buffer 
with 0.064% SDS. The gels were prerun for 4 hours at a 
constant voltage of 100 V, prior to loading samples. After 
the samples were loaded, they were run at 50 V until the dye 
front was well into the main gel, which was then run at a 
constant voltage of 100 V for the next 6-7 hours. 
After electrophoresis, the gels were stained over night 
in glacial acetic acid:95% methanol:water (1:5:5) containing 
0.1% coomassie brilliant blue. The following morning, the 
gels were destained in 1:5:5 solution of acetic acid-
methanol and water for 2 hours, followed by a solution 
containing 7.5% glacial acetic acid by vol., 5% of 95% 
ethanol by vol. and 87.5% by vol. of distilled water for 
another 2 hours. Finally the gels were soaked in 0.1% 
glycerol for 2 hours prior to drying. After drying, the 
gels were juxtaposed to Kodak X-Omat GBX-2 film, which were 
then sandwiched between two intensifying screens. This was 
then placed in a film holder, wrapped in aluminum foil and 
placed in a -70 °C freezer for 4 days, after which the X-ray 
film was developed. 
The Gg and G^ bands in the autoradiograms were then 
scanned by a laser densitometer, to guantitate extent of 
labeling. Each gel had three protein concentrations of both 
control and desensitized membranes for one time point. Both 
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control and desensitized membranes were on the same gel for 
comparison. The densitometric scan value of each band was 
plotted by a chart recorder, as peaks. All plots were 
photocopied, and each peak was cut out and weighed. The 
amount of CL membrane protein that was loaded on to each 
well was determined by the method of Lowry et al. (18), 
using BSA (fraction V) as standard. The weight of each peak 
was plotted against the amount of CL membrane protein 
actually loaded. The rational behind using three protein 
concentrations for each set of control and desensitized 
membranes, was to make sure that there was a linear 
relationship between extent of labeling and amount of 
protein used in the incubation mixture. In order to be 
within the linear range, the three protein concentrations 
used were approximately 160 ug, 80 ug and 40 ug 
respectively. The extent of labeling was calculated from 
the slopes of traces generated by plotting the three protein 
concentrations verses the weight of the scan. 
S49 Cyc- Cell Culture Cells were grown in Dulbeccos 
Modified Eagle Medium (DMEM), with 10% heat inactivated 
horse serum, containing 100 units/ml of penicillin and 75 
units/ml of streptomycin. Cells were kept at a density of 
0.75 - 1 x 10® cells/ml, and were grown in a 8 liter Bellco 
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spinner flask, In an atmosphere of 5% CO2 at 37 °C. The 
cells doubled approximately every 24 hours. 
MgBifrrang Preparation fgQin 549 Çyç- celle 
Puck's Saline G Four liters of Puck's Saline G was made 
up fresh before each eye" membrane preparation. 1.6 g of 
KCl, 0.6 g of KH2PO4, 32 g NaCl and 0.61 g Na^HPO* were 
dissolved in 4 liters of deionized double distilled water 
and cooled to 4 °C before use. 
Homoaenization Buffer Half a liter of homogenization 
buffer was also freshly prepared for use and cooled to 4 °C 
before use. Homogenization Buffer contained 20 mM Na-Hepes, 
125 mM NaCl, 1.0 mM dithlothreitol (DTT) and 1.0 mM EDTA. 
NaOH at 0.1 N was used to adjust the solution to pH 8.00. 
Cells in DMEM from the 8 liter Bellco spinner flask 
were poured in to 4 x 250 ml centrifuge bottles and spun at 
3,200 rpm for 15 minutes in Sorvall RT6000 centrifuge at 4 
°C, in a Sorvall HIOOO rotor. The supernatant from each 
bottle was carefully discarded in to a bucket containing 
bleach. The cell pellet in each centrifuge bottle was then 
resuspended in 200 ml of Puck's saline G (PSG) at 4 °C. The 
suspension of cells in PSG was then spun again at 3,200 rpm 
for 15 minutes in the Sorvall RT6000 centrifuge at 4 ®C and 
supernatant discarded. This washing procedure was repeated 
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thrice before the cells were suspended in homogenization 
medium (HM). The cells in HM were transferred to a 250 ml 
beaker and placed in a Tare Parr Bomb jar sitting on ice. 
The Parr Bomb was then filled with nitrogen gas until the 
gauge on Parr Bomb read 400 psi. The bomb was placed on ice 
at that internal pressure for a 20 minute period. A 250 ml 
beaker covered with parafilm, and punctured only to let the 
Parr Bomb nozzle in, was held and the pressure from the Parr 
Bomb slowly let out through the nozzle emptying in to the 
parafilm covered beaker. The 250 ml parafilm covered beaker 
was also set on ice. The lysed cells were then collected 
and diluted with equal amounts of HM. The mixture was then 
poured into 30 ml centrifuge tubes and spun at 1000 rpm in a 
Sorvall RC5 centrifuge for 5 minutes at 4 °C in a SS34 
rotor. The supernatant was then poured into another 30 ml 
tube and the pellet discarded. The collected supernatant 
after the first spin was then centrifuged at 20,000 x g for 
30 minutes at 4 °C. The resultant supernatant was discarded 
and the pellet resuspended in two volumes of homogenization 
buffer. The eye" membrane suspensions were then aliguoted 
in 100 ul volumes into 10 x 75 mm test tubes placed in an 
acetone-dry ice bath, before the tubes were capped and 
stored in a -70 °C freezer. 
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Preparation of luteal membrane cholate extract 
Cholic acid crystals were dissolved in hot 100% ethanol and 
gradually cooled, resulting in the recrystallization of 
cholic acid. The crystals were then filtered over Whatman # 
2 filter, washed with double distilled water at 4 °C, dried 
and the procedure repeated twice. The cholic acid crystals 
were solubilized and their pH adjusted to 7.5, using IH 
Trie-Base. Finally, the solution was dissolved in 10 mM 
Tris-HCl pH 7.5 and adjusted to a final concentration of 5% 
and stored at 4 °C. 
Cholate extraction of 1.6 mg of luteal membrane was 
performed by adding Tris-cholate at a final concentration of 
1% cholate in a total extraction mixture volume of 150 ul. 
The mixture was allowed to sit on ice for 30 minutes with 
frequent vortexing prior to centrifugation at 100,000 x g 
for 60 minutes. The clear supernatant enriched in Gg was 
then pipetted in 50 ul aliquots in to 10 x 75 mm glass tubes 
sitting in a dry ice-acetone bath. The frozen cholate 
extract was then stored in a -70 °C freezer until assayed. 
Cvc" Reconstitution Assay Cholate extracts 
were prepared from CL membranes from individual rabbits 
(both hCG-treated and controls) and a large cholate extract 
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prepared from membranes pooled from control rabbits, were 
used as a reference standard during each assay. 
Then 50 ul of 1% cholate extract in each of the three 
tubes (reference standard cholate extract, cholate extract 
of CL membranes from control animals and desensitized 
animals) were incubated for 20 minutes at 32.5 °c to kill 
any contaminating catalytic activity in the extracts. The 
extracts were then diluted five-fold with an ice-cold 
solution containing 0.5 mM ATP, 1.5 mM MgCl2 ,0.1 mM GTP and 
10 mM Tris-HCl, pH 8.6. Two serial dilutions were made of 
the extract so that each dilution had 0.2% cholate, 0.5 mM 
ATP, 1.5 mH MgClg, 10 mM Tris-HCl pH 8.6 and 0.1 mM GTP. 
Cyc" membranes were diluted so that the mixture contained 
0.5 mM ATP, 1.5 mM MgClg, 0.1 mM GTP and 10 mM Tris-HCl pH 
8.6; with 5 ul of the solution having approximately 15-20 ug 
of eye' membrane protein. Five microliters of the £ 
inactivated 0.2% cholate extract at three serial dilutions 
of approximately 3 ug, 1.5 ug and 0.75 ug were preincubated 
for 30 minutes at 4 °C with a 5 ul solution containing 0.5 
mM ATP, 1.5 mM MgClg, 0.1 mM GTP and 10 mM Tris-HCl pH 8.6, 
with or without eye" membranes. Final assay for cyclase 
activity in eye" alone, cholate extract alone at three 
serial dilutions and eye" plus cholate extract at three 
serial dilutions, were carried out for 20 minutes at 32.5 °c 
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In presence of 0.02% cholate, 20 nM MgCl2# 0.1 mM ATP, 1 inM 
EDTA, 1 nM cAMP, 20 mM creatine phosphate, 0.2 mg/ml 
creatine kinase, 0.1 mM 6TP and 0.02 mg/ml myokinase; and 
all, both in presence and absence of 10 mM NaF and or 100 uM 
ISO. 
Statistical Analysis A two way analysis of variance 
was performed for the effects of treatment and time, using 
PROC 6LM of SAS. Sums of squares were calculated from 
treatment, time and treatment x time interactions, using the 
extra sums of squares responsible. A complete nested design 
with factorial treatment were used, where one factor is time 
and the other is treatment. The Einot-Gabriel multiple 
comparison method was used to determine which means are 
different and the probabilities associated with these pre­
planned comparisons. 
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RESULTS 
AdenvlYl çyçlagg açtivitY in luteal m^mbrangg 
Adenylyl cyclase assays were performed as described in 
materials and methods. Table 1 presents a summary of the 
adenylyl cyclase activity in control luteal membranes at 
different time points after subcutaneous injection of 
rabbits with 0.9% saline. No significant change in the 
basal, oLH-, ISO-, NaF- and forskolin stimulable adenylyl 
cyclase activities are seen with time. ISO- and oLH-
stimulable adenylyl cyclase activities are approximately 2.5 
fold and 3.25 fold above basal levels respectively. In 
contrast, epinephrine treatment of rabbits resulted in 
altered adenylyl cyclase activity, as presented in Table 2 
and Fig 1. No change in basal adenylyl cyclase activities 
are seen in these desensitized membranes. On the other 
hand, epinephrine treatment resulted in loss of LH-, ISO-, 
NaF- and forskolin-stimulated adenylyl cyclase activity. 
Similar changes in LH-, ISO- and NaF-stimulated adenylyl 
cyclase activities were observed upon epinephrine treatment. 
At 1.5 h, LH-, ISO- and NaF-stimulable adenylyl cyclase 
activities were depressed by 24 to 30% and continued to 
decrease until 6 h, when stimulable cyclase activities were 
depressed by 45 to 52%. In contrast, forskolin stimulable 
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adenylyl cyclase activity remained at control levels at 1.5 
h, but was depressed by 30% at 3h and 45% at 6 h. By 24 h 
stimulable adenylyl cyclase activities returned to control 
values 
Beta-adrenergic receptors In control animals, beta-
adrenergic receptor number and affinity was unaltered 
throughout the study period, remaining at a concentration of 
130 fmol/mg membrane protein and had a Kd of 6 pM. In 
contrast, epinephrine treatment of rabbits resulted in loss 
of hgta-adrenergic receptor number and reduced affinity, as 
shown in Table 3 and Fig 2. At 1.5 h, 41% of beta-receptors 
were lost, and continued to decline until 6 h at which time 
bsta-receptor number was 31% of control values. By 24 h, 
bsta-receptor numbers were back to control levels. 
Epinephrine treatment also resulted in a reduction of beta-
receptor affinity by approximately 1.5 and 2 fold, at 3 h 
and 1.5 h respectively. 
LH/hCG receptors In control animals, no significant 
change in number or affinity of LH/hCG binding sites were 
observed, as shown in Table 4. Epinephrine treatment 
resulted in no change in receptor number throughout the 
study period. Epinephrine treatment resulted in a reduction 
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of LH/hCG receptor affinity by approximately 2 fold at the 3 
h, 6 h, and 12 h time points. Acid elution of CL membranes 
from both control and epinephrine treated animals showed no 
differences in their total and available LH/hCG binding 
sites. 
Regqnetitwted adenvlYl çyçXag^ activity 
Reconstituted adenylyl cyclase activities were determined as 
Indicated in materials and methods. NaF- and ISO-
reconstituted cyclase activities were found to be linear 
with protein content of cholate extracts, as shown in Fig 3. 
Both ISO- and NaF-reconstltuted activities in controls 
remained unchanged until 6 h, after which there was 
approximately a 20-25% drop in NaF- and a 15% drop in ISO-
reconstituted adenylyl cyclase activity as shown in Table 5 
and Fig 4. Epinephrine treatment resulted in the depression 
of ISO- and NaF-reconstltuted Gg activities at early time 
points (1.5 h-6 h). At 1.5 h, a 60-65% loss in ISO- and 
NaF-reconstltuted activities were observed. Reconstituted 
activities remained depressed for 6 h, after which time 
activities Increased, such that by 12 h, they were at 
control levels. Both ISO- and NaF-reconstltuted activities 
showed a similar pattern of depression on epinephrine 
treatment. 
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Baçterial toxin indvced labeling Qf an^ Gj-like 
proteins Bacterial toxin induced ADP-ribosylation of Gg 
and Gj^-like substrates in luteal membranes were carried out 
as described in materials and methods. Three identifiable 
cholera toxin substrates: alfihâs 42, alEhSs 45 and aloha^ 
46, and one pertussis toxin substrate alpha40 was seen. 
Epinephrine treatment resulted in a depressed ability of 
âitfibâs 46 and alDhag 45 to be ADP-ribosylated by cholera 
toxin, as seen in Fig 5. ûlchâg 46 was depressed 50% by 1.5 
h and continued to remain depressed until 6 h, after which 
values returned to control levels. Although alpha^ 45 was 
depressed to a lesser degree (15-25%) than alpha^ 46, it 
remained depressed longer (for 12 h) than alpha^ 46. Alpha^ 
45 returned to control levels by 24 h. Alpha^ 42 and alpha^ 
40 were unaltered throughout the study period. 
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DISCUSSION 
The present study shows that a subcutaneous injection 
of 2.5 mg epinephrine per kilogram body weight to 
pseudopregnant female rabbits, results in desensitization of 
their luteal adenylyl cyclase. Luteal membranes from ' 
epinephrine treated rabbits show: 1) a loss in LH-, ISO-, 
NaP- and forskolin-stimulable adenylyl cyclase activity; 2) 
a loss in bstâ-adrenergic receptor number and affinity; 3) a 
loss in LH/hCG receptor affinity but no loss in receptor 
number; 4) a loss in NaF- and ISO-reconstituted adenylyl 
cyclase activity and 5) depressed ability of alpha^ 46 and 
alBbag 45 to be ADP-ribosylated by cholera toxin, although 
no change in the alpha^ 42 and alshai 40 proteins were 
observed. 
Since epinephrine treatment depressed the ability of 
the luteal cyclase to be stimulated by a number of different 
agonists (LH, ISO, NaF and forskolin), it is indicative of a 
heterologous form of desensitization. Earlier studies (6) 
on epinephrine treated rats show only a small decrease in 
the LH stimulation of ovarian adenylyl cyclase activity at 
times (1 h) when epinephrine stimulation was partially 
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decreased (50% loss), or completely lost (3 h). On the 
other hand, in the rabbit we see that epinephrine treatment 
resulted in similar changes in LH-, ISO- and NaF-stimulable 
adenylyl cyclase activity, where a maximum of 45 to 50% 
depression of activity was observed at 6 h. Epinephrine 
treatment also altered the ability of luteal cholate 
extracts to reconstitute NaF- and ISO-stimulated adenylyl 
cyclase activity in S49 eye- membranes. The correspondence 
of depressed NaF-stimulated adenylyl cyclase activity and 
NaF-reconstituted activity up to 6 h following epinephrine 
treatment suggests that changes in Gg may be responsible for 
the altered response of the cyclase system to NaF. Earlier 
studies (23) with catecholamine desensitized turkey 
erythrocytes show that there is a 10-20% loss in NaF-
stimulable adenylyl cyclase activity, a 30% loss in ISO-
reconstituted activity, but no change in NaF-reconstituted 
activity. On the other hand, in epinephrine treated 
rabbits, we see a maximum of 60 to 65% loss in ISO- and NaF-
reconstituted activity. These results therefore show that 
epinephrine treatment of rabbits result in alteration of 
both NaF acting site and the beta-receptor coupling domain 
of luteal Gg: whereas in turkey erythrocytes, only the beta-
receptor coupling domain of Gg is altered. These studies 
also support the idea that a hormone binding to the same 
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receptor but in different cell types would elicit a 
different response, depending on the type and nature of the 
6 protein the receptor is coupled to. Since no change in 
forskolin-stimulable adenylyl cyclase activity was seen 
until 3 h, the catalytic unit of adenylyl cyclase appears 
not to have been altered 1.5 h after epinephrine treatment. 
Epinephrine treatment of rabbits also resulted in the loss 
of b@&a-adrenergic receptors, that paralleled changes in 
ISO-stimulated adenylyl cyclase activity. The 1.5 and 2 
fold decrease in beta-receotor affinity at 3 h and 1.5 h 
time points, together with beta-receotor loss suggests that 
changes in hsta-receptor may in part be responsible for loss 
of ISO-stimulable adenylyl cyclase activity. Since earlier 
studies in frog (10) and turkey erythrocytes (24) 
demonstrate phosphorylation of beta-receptors on agonist 
occupancy, resulting in either uncoupling of the receptor 
cyclase system and or down regulation of receptors; this 
argues in favour of fegfca-receptor phosphorylation in the 
rabbit CL upon catecholamine treatment. In the present 
study, since bgta-receptor levels continue to decline until 
6 h, whereas the affinity of receptors return to control 
values by then, it is therefore possible that a drop in 
beta-receptor affinity at early time points could be due to 
alteration of the coupling of G proteins to the receptor-
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adenylyl cyclase. On epinephrine treatment, since there is 
loss of liH-stimulable cyclase activity without change in 
total and available LH/hCG receptor number, it could be 
argued that the reduction in LH/hCG receptor affinity seen 
at early time points, could in part account for the loss in 
LH-stimulable adenylyl cyclase activity. The 2 fold drop in 
LH/hCG receptor affinity could be due to either altered G 
protein function or LH/hCG receptor phosphorylation or both. 
The recent (25,16,10) identification of a cytoplasmic beta-
adrenergic receptor kinase, that could at times be 
nonspecific, could specifically be phosphorylating the 
occupied beta adrenergic receptors and nonspecifically 
modifying the LH/hCG receptors. Earlier studies in turkey 
erythrocytes (26) demonstrate that cyclic nucleotide analogs 
such as 8-bromocyclic AMP or dibutryl cAMP could result in 
desensitization of the erythrocytes, similar to its 
desensitization by catecholamines. Also, studies (27) where 
purified hamster lung beta-adrenergic receptors were 
incubated with the catalytic subunit of cAMP dependent 
protein kinase, resulted in receptor phosphorylation. 
Therefore in rabbit CL, it is possible that both the beta-
adrenergic receptor kinase and cAMP dependent protein kinase 
may be involved in modulating the phosphorylation states of 
both LH/hCG- and fegia-adrenergic receptors that are coupled 
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to the adenylyl cyclase. Since hCG induced desensitization 
of rabbits results in depression of the alEhag 45 protein 
throughout the study period (Section I of thesis) and since 
on epinephrine treatment we see a reduction in affinity of 
LH/hCG receptors at 3, 6 and 12 h, as well as 20-25% 
depressed alpha^ 45 at those time points, this isomorph of 
alphag may be the protein that couples LH/hCG receptors to 
adenylyl cyclase. Because we see a greater extent of 
depression of alpha^ 46 (50%) at 1.5, 3 and 6 h time points, 
as well as a two fold loss in beta-receotor affinity at 1.5 
and 3 h, argues in favour of alpha^ 46 being the protein 
that couples bsta-receptors. The early (1.5 h) depression 
of alphag 46 by 50%, could account for the rapid uncoupling 
of the receptor and the G protein and therefore be a 
contributing factor to the loss of high affinity binding. 
Earlier studies with catecholamine-desensitized turkey 
erythrocytes (18) show no change in CT"*" induced ADP-
ribosylation of alphSg 42. These studies demonstrate that 
different transducing proteins interact with the same 
receptor-adenylyl cyclase complex in different tissues. 
Therefore, these studies show that epinephrine-induced 
desensitization of the rabbit CL involves loss and 
alteration of receptor and transducing proteins. These 
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studies also suggest that coupling and interaction of 
specific transducing proteins with their respective 
receptors enable multi-hormone target cells to identify, 
differentiate, regulate and respond to different hormone 
signals. 
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Table 1 Summary of adenylyl cyclase activity in control 
luteal membranes from (-)Epinephrine protocol® 
Time after Control 
Treatment Basai oLH^ ISO® Napd Forskolin 
pmole . min"l. mg"^. 
1.5 h M* 
SD' 
38 
±5 
120** 
±7 
94** 
±11 
496* 
±81 
551 
±136 
3 h 34 
±6 
1|8*** 84*** 
±14 
527*** 
±114 
518* 
±24 
6 h 59 
±21 
156*** 
±15 
121*** 
±23 
556*** 
±4 
678*** 
±184 
12 h 47 
±14 
136*** 
±19 
108** 
±9 
535** 
±105 
950** 
±61 
24 h 27 
±4 
116 
±18 
105 
±18 
506 
±83 
695 
±87 
48 h 39 
±11 
114 
±10 
89 
±5 
425 
±77 
621 
±147 
^Rabbit luteal membranes were incubated as outlined in 
Materials and Methods, in the presence and absence of oLH, 
ISO, NaF and forskolin, for 10 minutes at 32.5 °C. The 
concentration of membrane was 5-10 ug/50 ul assay. Adenylyl 
cyclase activity is expressed as the amount of [^^P]cAMP 
formed from added [alpha-^^PJATP. Values are mean ± SD of 
assays from four separate animals at each time point. Each 
assay was done in triplicates. 
^LH = Luteinizing hormone stimulable cyclase activity. 
°ISO = Isoproterenol stimulable cyclase activity. 
NaF = Sodium fluoride stimulable cyclase activity. 
®M = mean. 
jrSD = standard deviation. 
significantly different from desensitized (p<0.01). 
Significantly different from desensitized (p<0.005). 
Significantly different from desensitized (p<0.00l). 
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Table 2 Summary of adenylyl cyclase activity In control 
luteal membranes from (-)Epinephrine protocol^ 
Time after Control 
Treatment Basai oLH*) ISO® NaF* Forskolin 
pmole . min"^. mg"l. 
1.5 h K 39 93** 65** 357* 461 SD? ±9 ±10 ±9 ±54 ±36 
3 h 28 83*** 51*** 297*** 354* 
±14 ±5 ±13 ±22 ±57 
6 h 32 87*** 58*** 269*** 373*** 
±6 ±10 ±7 ±35 ±31 
12 h 36 100*** 78** 357** 718** 
±16 ±11 ±13 ±22 ±126 
24 h 34 114 95 555 674 
±8 ±10 ±10 ±88 ±150 
48 h 33 120 98 502 670 
±11 ±12 ±14 ±92 ±159 
^Rabbit luteal membranes were incubated as outlined in 
Materials and Methods, in the presence and absence of oLH, 
ISO, NaF and forskolin, for 10 minutes at 32.5 °C. The 
concentration of membrane was 5-10 ug/50 ul assay. Adenylyl 
cyclase activity is expressed as the amount of [^^P]cAMP 
formed from added [alpha-^^P]ATP. Values are mean ± SD of 
assays from four separate animals at each time point. Each 
assay was done in triplicates. 
^LH = Luteinizing hormone stimulable cyclase activity. 
^ISO = Isoproterenol stimulable cyclase activity. 
NaF = Sodium fluoride stimulable cyclase activity. 
®M = mean. 
^SD = standard deviation. 
significantly different from control (p<0.01). 
Significantly different fron control (p<0.005). 
significantly different from control (p<0.001). 
Fig 1: Effect of epinephrine treatment on luteal adenylyl 
cyclase activity. Assays were performed for 10 
min under standard assay conditions as described 
in materials and methods, in the presence or 
absence of 10 ug/ml oLH, 0.1 nM ISO, 10 mM NaF and 
0.1 mM forskolin. Membrane protein concentration 
was 6-10 ug/50ul assay. Values were calculated by 
dividing the mean adenylyl cyclase activity from 
treated animals by the mean adenylyl cyclase 
activity from control animals and multiplied by 
100 
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Table 3 Summary of Scatchard analysis of (-)-3-[^^®I]iodo 
cyanoplndolol binding to luteal membranes from 
control and epinephrine treated rabbits* 
Time After Control Epi-Treated 
Treatment 
®MAX KD ®MAX Ko 
(fmole/mg) (PM) (fmole/mg) (pM) 
1.5 h M^ 125 8 74** 13** 
SD® ±17 ±3 ±15 ±4 
3 h 143 6 50** 9* 
±17 ±1 ±9 ±3 
6 h 110 5 41** 5 
±9 ±0.6 ±14 ±0.3 
12 h 122 5 63** 6 
±21 ±0.6 ±13 ±1 
24 h 148 6 150 7 
±4 ±0.4 ±27 ±1 
48 h 123 8 134 6 
±15 ±2 ±19 ±0.6 
^Rabbit luteal membranes were incubated with varying 
concentrations of [^^®I]ICYP as outlined in Materials and 
Methods. The concentration of membrane was 8-10 ug/500 ul 
assay. All assays were carried out in the absence and 
presence of 10 uM (")propranolol. Specific binding was the 
difference between total [^^®I]ICYP precipitated in absence 
and presence of excess (-)propranolol. Values are mean ± SD 
of four separate animals at each time point. 
^ » mean. 
°SD = standard deviation. 
significantly different from controls (p<0.05). 
Significantly different from controls (p<0.001). 
Effect of (-)epinephrine treatment on beta-
adrenergic receptor content in rabbit corpora 
lutea. Note that the time dependent loss of beta-
receptors is similar to the time dependent loss of 
isoproterenol-stimulable adenylyl cyclase activity 
after (-)epinephrine treatment. Each value 
represents the mean ± SE, n = 4 in each case. 
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Table 4. Summary of Scatchard analysis of iodo-hCG 
binding to luteal membranes from control and 
epinephrine-treated rabbits® 
Time After 
Treatment 
Control 
®MAX KD 
Epinephrine 
Treated 
®MAX *0 
(fmol/mg) (PM) (fmol/mg) (pM) 
1.5h 626+75 421±51 700+65 608+71 
3h 478±23 397+79 708±31 815+40* 
6h 589+43 529+40 712+42 958+41* 
12h 537+71 405±34 707+27 891+122 
24h 525+57 412±32 520+13 522+83 
48h 466+43 389+70 539+50 471+37 
^Rabbit luteal membranes from both control and 
epinephrine-treated animals were washed with neutral, 0.2 M 
Sodium acetate buffer for 20 minutes at 4 prior to 
Scatchard analysis. Each value represents mean ± SE of four 
separate animals at each time point. Note similar and 
Kg values were obtained in acid washed membranes, inoîcating 
no difference in total and available LH/hC6 receptor content 
and affinity (not shown). 
*Significantly different from controls (P<0.001). 
Fig 3 Reconstituted NaF- and ISO-stinulable adenylyl 
cyclase activities at three serial dillutions of 
chelate extracts from a 3 h control and 3 h 
desensitized rabbit luteal membranes. Data shown 
are the mean triplicate determinations. This 
demonstrates the linearity in reconstituted 
cyclase activity observed in all reconstituted 
experiments. 
Rabbit CL. o 3 h Control. A3 h Epi-Treated 
1 2 
Cholate Extract Protein in ug 
M 
W 
m 
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Table 5 Summary of ISO- and NaF-reconstituted adenylyl 
cyclase activity in control and epinephrine-treated 
rabbits® 
Time After Control Epi-Treated 
pmole/mg^Vzo min"^ 
Treatment Napb ISO® NaF^ ISO® 
1.5 h M* 1007 282 338* 32 
SD® ±103 ±4 ±12 ±2 
3 h 1113 252 379* 97 
±136 ±23 ±77 ±13 
6 h 1104 257 398* 92 
±136 ±18 ±79 ±18 
12 h 687 224 666 217 
±126 ±96 ±67 ±52 
24 h 795 217 845 243 
±28 ±54 ±59 ±36 
48 h 795 232 849 257 
±19 ±47 ±70 ±40 
^Chelate extracts of luteal membranes from four control 
and four Epi-treated rabbits for each time point, were 
pooled separately. The pooled cholate extracts were then 
reconstituted in to eye- membranes, as indicated in 
Materials and Methods. Values are the mean ± SD of three 
separate assays, each assay done in triplicates. 
^NaF = sodium fluoride reconstituted cyclase activity, 
®ISO = isoprotetenol reconstituted cyclase activity. 
°M = mean. 
®SD = standard deviation. 
Significantly different from controls (p<0.0001). 
Fig 4: Effect of epinephrine treatment on ISO- and NaF-
reconstituted adenylyl cyclase activity. Chelate 
extracts of luteal membranes were prepared from 
four control and four hormone treated animals for 
each time point. Chelate extracts were then 
reconstituted in to S49 eye- membranes and their 
ISO- and NaF-stimulable adenylyl cyclase activity 
assayed, as described in materials and methods. 
Values are mean ± SD of three separate assays, 
each assay done in triplicate 
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Fig 5: Effects of epinephrine treatment on the extent of 
ADP-ribosylation of three aloha Gg isomorphe and 
alpha Gj-like protein, by cholera toxin and 
pertussin toxin respectively. [^^P]ADP-ribose 
labeling of Gg and G^ proteins were carried out as 
described in materials and methods. Luteal 
membranes from four control and four treated 
animals were studied for each time point 
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SECTION III DEVELOPMENT OF A HIGH YIELDING AND 
STEROIDOGENICALLY ACTIVE RABBIT LUTEAL CELL CULTURE 
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ABSTRACT 
Corpora lutea were isolated from New Zealand white 
rabbits in their seventh day of pseudopregnancy. The luteal 
tissue was sliced into small pieces and then incubated at 
32.5 °C with collagenase, DNase and trypsin inhibitors to 
dissociate cells. Cell suspensions were pelletted, washed 
four times with Ca^^-free Kreb's Ringer Bicarbonate Buffer 
and resuspended in Dulbeccos Modified Eagles Medium 
containing gentamycin and streptomycin. Cells were plated 
in 24 well multi-well tissue culture Falcon plates, each 
well containing 1 x 10® cells/well/ml either in the presence 
or absence of different concentrations of BSA or fetal calf 
serum or a combination of both. Cells did best in Dulbeccos 
Modified Eagles Medium containing 0.5% BSA. In this defined 
medium, cells were morphologically and physiologically 
healthy up to 30 hours. These cultured cells also responded 
to hormonal stimulation. When challenged with either 1 uM 
isoproterenol or 1 ug/ml human chorionic gonadotropin, the 
cells responded by a 4 to 7 fold increase in progesterone 
secretion. 
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INTRODUCTION 
In order to understand cellular regulation independent 
of the variables present in vivo, isolated cellular 
preparations, that retain both morphological and 
physiological characteristics have to be developed. 
Isolated cells in culture can then be manupulated or 
challenged with various drugs, hormones or chemicals to 
study and understand various effects of these treatments. 
Information gained from both in vivo and in vitro studies, 
could then help decipher some of the physiology and 
biochemistry of the tissue. 
The endocrine function of the ovary is dependent on the 
state of follicular maturation and the state of 
differentiation of luteal cells. The function of the ovary 
and its cellular contents has been studied by using ovarian 
tissue slices, whole corpora lutea or luteal slices and, in 
recent years, using isolated granulosa or luteal cells. The 
function of luteal cells has been studied either by using 
granulosa cells that have been allowed to luteinize in 
culture (1-3) or by using isolated luteal cells (4-7). 
Various tropic and lytic endocrine regulators have been 
identified that regulate and maintain the functional 
integrity of the corpus luteum. In order to identify the 
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functions of these regulators on luteal tissue and to 
understand the formation, growth, function and death of the 
corpus luteum, isolated luteal cell preparations are a 
necessity. The intentions of this study was to develop a 
long term (3 to 4 days) luteal cell culture that remained 
viable and functional in a defined culture medium. This 
cell culture could then be used as a tool to study the 
effects of catecholamines and gonadotropins on luteal 
adenylyl cyclase. 
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MATERIALS AND METHODS 
Materials Bovine serum albumin fraction V, human 
chorionic gonadotropin (hCG), follicle stimulating hormone 
(FSH), DNase, trypsin inhibitor, gentamycin, streptomycin 
and triton X-100 , were purchased from Sigma Chemical Co., 
St. Louis, MO. Sodium azide, EDTA, benzene, hexane, 
toluene, 2-,5-diphenyloxozole (PPO) and 1,4-Bis (2-,5-
phenyloxozolyl) benzene (POPOP), were from Fisher 
Scientific. Dulbecco's Modified Eagles Medium (DMEM) and 
fetal calf serum, were from GIBCO laboratories. Grand 
Island, NY. Collagenase fraction IV was from Cooper Bio 
Medicals. Dextrane coated charcoal was from Nutritional 
Biochemical Corporation, Cleveland, Ohio. Progesterone 
antibody # 337 was a gift from Dr. G. D. Niswender. 
[1,2,6,7- ^H(N)]-Progesterone was from NEN. Isoproterenol 
was from Sterling-Winthrop Research Institute, Rensselaer, 
NY. 
Animals Pseudopregnant, New Zealand white rabbits 
weighing 3 to 4 kg were used in this study. Pseudopregnancy 
was induced in these animals by injecting 0.3 lu porcine FSH 
subcutaneously, twice daily, for three days, followed by 100 
lU hCG i.v. on the fourth day. On the seventh day after hCG 
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Injection, the animals were euthenized by cervical 
dislocation. Ovaries were removed and placed in ice-cold 
Ca+2-free Kreb's Ringer Bicarbonate Buffer, pH 7.4, until 
isolation of corpora lutea from the ovaries. Each corpus 
luteum was sliced into four pieces with a sterile blade, 
thoroughly washed with Ca+^-free Kreb's Ringer Bicarbonate 
Buffer, weighed and placed on ice, prior to cell isolation. 
Isolation of Luteal Cells A gram of chopped rabbit 
corpus luteum was placed in a 25 ml Erlenmeyer flask, 
containing 4 ml of dissociation medium. The dissociation 
medium contained 1000 lU collagenase fraction IV, l mg 
DNase, 3 mg of soybean trypsin inhibitor type 11-S and 2% 
bovine serum albumin, all dissolved in Ca*^ -free Kreb's 
Ringer Bicarbonate Buffer. The Erlenmeyer flask with its 
contents was placed in a 32.5 °C rocking water bath for 10 
minutes. After 10 minutes, the flask with contents was set 
on ice for approximately 30 seconds, allowing large pieces 
of tissues to settle at the bottom of the flask, prior to 
aspirating out 2 ml of the dissociated cell suspension. The 
aspirated cell suspensions in dissociating medium was 
immediately diluted five-fold with ice-cold Ca+^-free Kreb's 
Ringer Bicarbonate Buffer, prior to spinning at 1000 rpm for 
5 minutes in a Sorvall 6000 centrifuge, using a Sorvall 
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HlOOO rotor, at 4 °C. After aspirating out the supernatant, 
the resulting pellet was resuspended in 5 ml of DMEM and 
centrifuged again at 1000 rpm for 5 minutes at 4 °C. The 
above procedure was repeated once more, prior to 
resuspension of the final pellet in 2 ml of DMEM. 
This procedure of removing 2 ml of luteal cell 
suspensions from the 25 ml Erlenmeyer flask every 10 
minutes, was continued until no luteal tissue was left in 
the flask. The washed and concentrated cell suspensions in 
DMEM were then pooled, counted and their viability 
determined, prior to plating. 
Cell Yield and Viability Cells were counted using a 
hemocytometer and the viability of cells determined by the 
dye exclusion procedure. This method is based on the 
principle that viable cells (cells with intact membranes) do 
not take up certain dyes. Trypan blue was used to determine 
viability. Two hundred micro liters of 0.4% trypan blue was 
diluted with 0.8 ml of DMEM. Five hundred micro liters of 
this diluted trypan blue was added to 0.5 ml of diluted cell 
suspensions in DMEM, mixed thoroughly and allowed to stand 
for 15 minutes, then mixed thoroughly, prior to counting. 
With the cover slip in place, a small amount of trypan blue-
cell suspension was transferred with a pipette to both 
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Chambers of the hemocytometer. Both viable and nonviable 
(stained cells) cells were counted in the 1 nun center square 
and the four 1 mm corner squares, keeping separate counts of 
viable and non viable cells. This procedure was repeated 
for chamber two also. Whenever, cells appeared in clusters 
or when less then 50 cells were observed per square, the 
procedure was repeated after adjusting to an appropriate 
dilution factor. Each square of the hemocytometer, with 
cover slip in place, represents a total volume of 0.1 mm^ or 
10"* cmf. Since 1 cm^ is equivalent to 1 ml, the subsequent 
cell concentration per ml was determined using the following 
calculation: 
CELLS PER ML = The average count per square x 10*. 
Total cells were then determined by the following 
calculation: 
TOTAL CELLS = Cells per ml x the dilution factor x the 
original volume of fluid from which cell 
samples were removed. 
Cells were then diluted to 1 x 10® cells per ml in DMEM 
containing gentamycin and streptomycin, and plated on to 24 
well multi-well Falcon 3847 sterile polystyrine dishes, with 
1 ml per well. The dishes with cells were then placed in a 
37 ®C sterile incubator, with a humidified atmosphere of 5% 
CO2 and 95% air. After 6 hours of incubation, the medium 
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was replaced with either DMEM, 0.5% BSÂ in DMEM, 0.5% BSA in 
DHEM plus 1 ug/ml OLH, 0.5% BSA in DMEM plus 1 UM 
isoproterenol and with either 1%, 2.5% or 5% fetal calf 
serum in DMEM. A cell count was done on the 6 h replaced 
medium for each well, to keep track of cell loss. The 
amount of progesterone secreted in to the medium was assayed 
by using a progesterone radioimmunoassay (8). 
Progesterone Radioimmuno Assay Progesterone in 
luteal cell culture medium was extracted with benzene-hexane 
(1:2,vol/vol) using a modified version of the procedure 
described by Louis et al. (9). An aliquot of 200 ul of 
culture medium was extracted in duplicated for each sample. 
For every tenth tube, a recovery tube was included. In each 
recovery tube, 100 ul of 5,000 cpm of l,2,6,7-[%](H)-P4 (97 
Ci/mmol) in ethanol was added and dried down using a gentle 
stream of air, while the samples sat on a multiblock heater 
under the hood. An aliquot of 200 ul medium was then added 
to a recovery tube and extracted. All tubes to be extracted 
contained 2 ml of the extraction mixture. After addition of 
extraction mixture, the tubes were vortexed. The tubes were 
then frozen in an acetone-ethanol (l:l::v/v) bath containing 
dry ice. The recovery tube extracts were decanted directly 
into scintillation vials, prior to evaporation. Recoveries 
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were run to determine extraction efficiency of progesterone 
from medium samples. The efficiency of recovery was about 
95%. In order to determine the amount of progesterone being 
extracted, duplicate samples of total counts were were added 
to the group of recoveries. These total count samples 
contained 200 ul of recovery tracers (5,000 cpm/150 ul) 
which was evaporated to dryness, prior to addition of 10 ml 
of toluene-based scintillation cocktail and counting. The 
samples were then counted in a Packard Tricarb 300 
scintillation counter which was programmed for counting 
tritiated progesterone for 10 min. The duplicates of each 
sample were decanted into 12 x 75 mm disposable culture 
tubes and evaporated to dryness before assaying for 
progesterone, using a slightly modified radioimmunoassay 
procedure described previously by Anderson et al. (10) and 
by using the characterised antibody: GDN-337 (11,12). 
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RESULTS AND DISCUSSION 
The procedure described in materials and methods, 
permitted the recovery of free and viable luteal cells. 
Each gram of rabbit luteal tissue yielded an average of 25 x 
10^ cells. The viability of the cell suspension was in the 
range of 94 to 97%. These cell preparations dispersed freely 
in DMEM without the addition of methyl cellulose or serum to 
the cell preparation. Methyl cellulose and serum is 
sometimes necessary to prevent clumping of these cells 
(4,13,14). Of the various medium conditions used, 0.5% BSA 
in DMEM was found to be optimal for cell survival, for a 
period of 30 hours. Without any hormonal treatment, 10^ 
cells secreted about 4 ng of progesterone into the culture 
medium in 24 hours, and approximately 3 ng in a 12 h period. 
Progesterone secretion by these cells increased 4 to 7 fold 
when challenged with stimulatory hormones like oLH and 
isoproterenol, indicating that the cells were not only 
structurally viable but also hormonally responsive and 
therefore physiologically functional. This procedure 
therefore enables the recovery of high yielding luteal cells 
that are both physiologically and morphologically viable and 
are capable of responding to hormonal challenge, even after 
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30 hours In culture. These studies also demonstrate the 
degree and effectiveness to which these cells respond to 
hormonal stimulation at various times In culture (Table-1). 
Further studies to prolong life of these cells In a 'defined 
medium' have to be undertaken. Although this luteal cell 
culture system Is not adequate for long term studies (3 to 4 
days), It Is effective for short-term studies on the 
structural and biochemical aspects of luteal cells In a 
defined environment. 
155 
REFERENCES 
1. Kumarl, G. L., and Channing, C. P. J. Steroid Biochem. 
11, 781, 1979. 
2. Henderson, K. M., and McNatty, K. P. J. Endocrinolgy 
21, 71, 1977. 
3. Tureck, R. W., and Strauss, J. F. J. Clin. Endo. Metab. 
Sir 367, 1982. 
4. Liu, T-C., and Gorski, J. Endocrinology &&, 419, 1971. 
5. Gospodarowicz, 0., and Gospodarowicz, F. Endocrinology 
âfl, 1427, 1972. 
6. Wu, D. H., Wiest, W. G., and Enders, A. C. 
Endocrinology 1378, 1976. 
7. Simmons, K. R. Proc. Soc. Exp. Biol. Med. 152. 366, 
1976. 
8. Musah, A. I., Ford, J. J., and Anderson, L. L. 
Endocrinology 115. 1876, 1984. 
9. Louis, T. M., Hafs, H. D., and Seguin, B. E. Proc. Soc. 
Exp. Biol. Med. Ml, 152, 1973. 
10. Anderson, L. L., Hard, D. L., and Kertiles, L. P. Am. 
J. Physiol. 22â, E335, 1979. 
11. Niswender, G. D. Steroids 22., 413, 1973. 
12. Gibori, G., Pintezak, E., and Rothchild, I. 
Endocrinology 100. 1483, 1977 
13. Schneider, H., Shaw, M. W., Muirhead, E. E. and Smith, 
A. Exp. Cell Res. lâ, 631, 1965. 
14. Bryant, J. c. Ann. N.Y. Acad. Sci. 139. 143, 1966. 
156 
Table 1 Summary of progesterone RIA on medium from rabbit 
luteal cells, cultured for different lengths of time 
and treated differently^ 
Medium Source Average Progesterone conc. 
for RIA in ng/10^ cells 
1. 12 h cell culture n = 6 
2. 24 h cell culture n = 2 
3. 40 h cell culture n = 2 
4. 24 h cell culture challenged 
with medium for 1 h n = 2 
5. 24 h cell culture challenged 
with 1 uM ISO for 1 h n = 2 
6. 24 h cell culture challenged 
with 1 ug/ml oLH for 1 h n = 2 
7. Serum from 7 day 
pseudopregnant rabbit n = 2 
3.07 ng/12 h 
4.17 ng/24 h 
5.5 ng/30 h 
0.77 ng/h 
3.45 ng/h 
4.31 ng/h 
61.21 ng/ml 
^Medium from rabbit luteal cell cultures were extracted 
and assayed for progesterone by radioimmunoassay, as 
described in materials and method. Values represent mean 
estimates of medium from two to six samples. The serum 
concentration of progesterone of 7 day superovulated 
pseudppregnant rabbits was estimated by the same method as 
Indicated in materials and methods. 
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GENERAL SUMMARY 
Hormonal regulation of the receptor-adenylyl cyclase 
system and target cell responsiveness to hormonal 
stimulation, has been demonstrated in a number of tissues 
(1-13). It has frequently been shown that treatment with a 
hormone is followed by subsequent loss of target cell 
responsiveness either to the same hormone (homologous 
desensitization) and sometimes to different hormones as well 
(heterologous desensitization). Earlier studies in various 
tissues show that hormone-induced desensitization of target 
cells results in either one or more of the following 
processes: uncoupling of receptor-adenylyl cyclase system, 
phosphorylation of the receptor, receptor down regulation, 
or G protein alteration (14-20). 
The corpus luteum in rabbits contains an adenylyl 
cyclase system that is responsive to both LH/hCG and beta-
adrenergic agonist, that act on the same cyclase system 
(21). The mechanisms of adenylyl cyclase activation and or 
desensitization by LH/hCG or beta-adrenergic agonists are 
different (22). In order to understand some of the 
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molecular mechanisms Involved in hCG- and catecholamine-
induced desensitization of the rabbit luteal cyclase system, 
the present study was undertaken. In this study, the 
components of luteal adenylyl cyclase: LH/hCG- and beta-
adrenergic receptors, the transducing proteins and the 
catalytic unit were assayed for functional changes or 
alterations, after injection of hormones to pseudopregnant 
rabbits 
The present study demonstrates that treatment of 
pseudopregnant rabbits with hCG or epinephrine results in 
desensitization of their luteal adenylyl cyclase. Treatment 
with hCG results in both homologous and heterologous 
desensitization, there is an early loss of LH-stimulable 
adenylyl cyclase, followed later by loss of ISO-stimulable 
adenylyl cyclase activity. In contrast, epinephrine 
treatment results in heterologous desensitization even at 
very early time points. Because of irreversible binding of 
hCG to its receptor (22), we see elevated basal cyclase 
activity on hCG treatment. On the other hand, due to 
reversible binding of epinephrine to its receptor (22), no 
change in basal cyclase activity is seen on epinephrine 
treatment. hCG induced desensitization results in loss of 
both LH/hCG and beta-adrenergic receptors, contrary to 
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epinephrine treatment where loss of only beta receptors are 
seen. In this regard, epinephrine-induced desensitization 
is more specific. On hormonal treatment, besides loss of 
receptors, there is significant reduction of receptor 
affinity. hC6 treatment results in a five-fold reduction of 
LH/hCG receptor affinity 12 h after treatment. Epinephrine 
treatment on the other hand, results in a 1.5 to 2-fold drop 
in beta-receptor affinity at 1.5 h and 3 h and also a 
decrease of LH/hCG receptor affinity at 3, 6 and 12 h. On 
epinephrine treatment, there is no loss in LH/hCG receptor 
number but a loss in LH-stimulable adenylyl cyclase activity 
is seen, suggesting that the transducing protein coupling 
the LH receptor to adenylyl cyclase is altered. 
S49 eye- reconstitution studies indicate that hCG 
treatment results in alteration of the coupling domain of Gg 
prior to alteration of the NaF stimulating site; whereas on 
epinephrine treatment both domains are altered 
simultaneously. The dissociation of NaF- and ISO-
reconstituted activity on hCG treatment, confirms the 
existence of two functional domains on Gg that are separate: 
one for NaF-induced stimulation and the other for receptor 
coupling. 
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Studies on cholera toxin and pertussis toxin induced 
ADP-ribosylatlon of Gg and Gj^-like substrates in rabbit 
luteal membranes demonstrate the presence of three Gg 
(alEhas 42, alDhSg 45 and alsMs 46) and one G^-like 
protein. Assay of ADP-ribosylable activity of all four 
isomorphs of 6 protein after hC6 and epinephrine treatment, 
suggests that the alphag 45 protein couples LH/hCG receptor 
and alBhSg 46 couples to fegta-adrenergic receptor. In 
addition, since hCG treatment elevates the alnhaj 40 protein 
at early time points, this increase may be in part 
responsible for the observed loss of LH stimulation. On hCG 
treatment, alohag 45 is depressed throughout the study 
period suggesting that this transducing protein interacts 
with LH/hCG receptor. Moreover, since epinephrine treatment 
results in depressed alpha^ 45 at 3, 6 and 12 h that is 
associated with a reduction in LH/hCG receptor affinity at 
the same time points also supports the idea that alpha^ 45 
couples LH/hCG receptors to adenylyl cyclase. The 
significantly depressed state of alpha^ 46 at early time 
points (1.5 h - 6 h) after epinephrine treatment correlates 
well with loss of fesfea-receptor affinity, thereby supporting 
the argument that alpha^ 46 interacts with the beta-receptor 
in the rabbit CL. Since the rabbit CL is responsive not 
only to LH/hCG and fesÊâ-adrenergic agonists (21-24), but is 
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also responsive to prostaglandins (23) and prostacyclins 
(25) stimulation, alpha^ 42 could potentially be the 6 
protein that would transduce stimulatory signals generated 
by these prostanoids. 
These studies therefore suggest that hormone-induced 
desensitlzatlon of the adenylyl cyclase system is a complex 
phenomenon involving alteration and loss of hormone 
receptors and alteration of the transducing proteins. The 
study strongly suggests that different types of receptors 
Interact with different 6 proteins. In a situation like the 
rabbit luteal tissue, where more than one receptor Interacts 
with the same cyclase in a cell and produce the same second 
messenger (cAMP), the selective Interaction of a specific G 
protein with its own receptor type would enable the cell to 
distinguish between different hormonal inputs. 
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